Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	(+)-(s)-2-(6-methoxynaphthalen-2-yl) propanoic acid	Propanoic acid	1件: D02310 💬	-	-	1件: 271 💬
2	(2r)-2-propyloctanoic acid	-	-	-	-	1件:  2  💬
3	(2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-y1] butanamide	-	-	-	-	1件: 309 💬
4	(2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-yl] butanamide	-	-	-	-	1件: 309 💬
5	(6r)-4, 5, 6, 7 - tetrahydro-n6-propyl-2,6-benzothiazolidiamine dihydrochloride monohydrate	-	-	-	-	1件:  2  💬
6	(6s)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol	-	-	-	-	1件:  6  💬
7	(r)-(-)-2-propyloctaroic acid	-	-	-	-	1件:  2  💬
8	(r)-3-(1-oxo-propoxy)-4-(n,n,n-trimethyl amonium chloride)-butanoic acid	Butyric Acid	1件: D05866 💬	-	-	1件: 97 💬
9	(s)- 2- amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol	-	-	-	-	1件:  6  💬
10	(s)-3-((3-(1-((6-(3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium	-	-	-	-	1件: 86 💬
11	**comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter.	-	-	-	-	1件: 86 💬
12	0 mg prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 44 💬
13	0,5 mg prevenar i.m.	-	-	-	-	1件: 51 💬
14	10% nifedipine cream	Nifedipine	1件: D00437 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 50 💬
15	10% nitroglycerine in propylene glycol, usp	Nitroglycerin	2件: D00078, D00515 💬	-	-	1件: 51 💬
16	17beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one	-	-	-	-	1件: 75 💬
17	17ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one	-	-	-	-	1件: 75 💬
18	1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-	-	-	-	-	1件:  6  💬
19	1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea	-	-	-	-	1件:  6  💬
20	1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-	-	-	-	-	1件:  6  💬
21	1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea	-	-	-	-	1件:  6  💬
22	2'-o-(2-methoxyethyl)-d-ribose antisense oligonucleotide targeting glial fibrillary acidic protein messenger ribonucleic acid	Ribose	-	-	-	1件: 131 💬
23	2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester	-	-	-	-	1件: 13 💬
24	3-(3-(3,5-dimethyl-1h-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid	Pyrazole	-	-	-	1件: 28 💬
25	5 mg prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 44 💬
26	5% lidocaine/5 mg/ml 0.02% estradiol compound cream	Estradiol	11件: D00105, D00358, D01413, D01617, D01953, D02086, D04061, D04063, D04064, D04065, D08127 💬	7件: ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	12件: Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway	1件: 226 💬
27	5-aminosalicylic acid(5-asa) and/or prednisone	Aminosalicylic acid	3件: D00162, D00377, D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
28	5-probe cocktail	-	-	-	-	1件: 254 💬
29	68ga-bnota-prgd2	-	-	-	-	1件: 46 💬
30	90 mg hydrocortisone acetate suppository with sephure suppository applicator	Acetate	2件: D00088, D00165 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
31	[rvt-1601 (in precedenza pa101b)]	-	-	-	-	1件: 85 💬
32	A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (cbus)	-	-	-	-	1件: 60 💬
33	A multistrain probiotic product (dsf)	-	-	-	-	1件: 97 💬
34	Abatacept prefilled syringe	Abatacept	1件: D03203 💬	2件: CD80, CD86 💬	12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis	1件: 46 💬
35	Abp 959 - proposed biosimilar to eculizumab	Eculizumab	1件: D03940 💬	1件: C5 💬	9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	1件: 62 💬
36	Access program - sildenafil citrate, viagra, revatio	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
37	Act-385781a (actelion epoprostenol)	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
38	Acthar injectable product	-	-	-	-	1件: 46 💬
39	Adalimumab prn	Adalimumab	1件: D02597 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 96 💬
40	Adalimumab, plus prednisone	Adalimumab	2件: D00473, D02597 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
41	Adalimumab, solution for injection 40 mg/ (0.8 ml) pre-filled syringe	Adalimumab	1件: D02597 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
42	Adeno-associated viral (aav) serotype 8 (aav2/8) vector with liver-specific thyroxine-binding globulin (tbg) promoter, driving the expression of the human arsb gene	Levothyroxine	2件: D01010, D08125 💬	2件: THRA, THRB 💬	2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway	1件: 19 💬
43	Advagraf prolonged-release hard capsules	-	-	-	-	1件: 299 💬
44	Agua para preparaciones inyectables	-	-	-	-	1件: 78 💬
45	Aldesleukin	Aldesleukin	1件: D00748 💬	3件: IL2RA, IL2RB, IL2RG 💬	14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor	4件: 49, 65, 96, 97 💬
46	Alirocumab	Alirocumab	1件: D10335 💬	1件: PCSK9 💬	1件: Cholesterol metabolism	1件: 79 💬
47	Alirocumab sar236553 (regn727)	Alirocumab	1件: D10335 💬	1件: PCSK9 💬	1件: Cholesterol metabolism	1件: 79 💬
48	Alkalinized lidocaine-heparin	Heparin	4件: D00358, D02086, D07510, D08127 💬	6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬	4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction	1件: 226 💬
49	Allogeneic mesenchymal precursor cells	-	-	-	-	1件: 46 💬
50	Allogeneic neural retina-derived human neural retinal progenitor cells ex vivo expanded	-	-	-	-	1件: 90 💬
51	Alpha 1-proteinase inhibitor	Alpha-1-proteinase inhibitor	-	-	-	1件: 231 💬
52	Alpha 1-proteinase inhibitor (human)	Alpha-1-proteinase inhibitor	-	-	-	1件: 231 💬
53	Alpha-1 proteinase inhibitor (human)	-	-	-	-	1件: 231 💬
54	Alpha1-proteinase inhibitor	Alpha-1-proteinase inhibitor	-	-	-	2件: 231, 299 💬
55	Alpha1-proteinase inhibitor (human)	Alpha-1-proteinase inhibitor	-	-	-	2件: 231, 299 💬
56	Alprostadil	Alprostadil	2件: D00180, D02705 💬	1件: PTGER1 💬	4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer	2件: 51, 70 💬
57	Ambrisentan 5mg film-coated tablets [marketed product]	Ambrisentan	1件: D07077 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
58	Amitriptyline, fluoxetine and tramadol alone (control group)	Amitriptyline	6件: D00326, D00809, D00823, D01355, D07448, D08623 💬	3件: OPRM1, SLC6A2, SLC6A4 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	1件: 78 💬
59	Amorphous calcium carbonate	Calcium	2件: D00932, D10802 💬	-	-	1件: 235 💬
60	Androgel 10 grams of gel containing 100 mg of testosterone	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	1件: 13 💬
61	Antioxidant plus pregabalin	Pregabalin	1件: D02716 💬	4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬	7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway	1件: 298 💬
62	Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed	Apomorphine	2件: D02004, D07460 💬	2件: DRD1, DRD2 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
63	Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed	Apomorphine	2件: D02004, D07460 💬	2件: DRD1, DRD2 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
64	Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed	Apomorphine	2件: D02004, D07460 💬	2件: DRD1, DRD2 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
65	Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed	Apomorphine	2件: D02004, D07460 💬	2件: DRD1, DRD2 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
66	Atenolol or propranolol	Atenolol	3件: D00235, D00483, D08443 💬	3件: ADRB1, ADRB2, ADRB3 💬	11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 167 💬
67	Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv)	Adenosine	1件: D00045 💬	4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬	12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 65 💬
68	Autologous mesenchymal cell product	-	-	-	-	1件: 13 💬
69	Avatrombopag (proposed)	Avatrombopag	1件: D10306 💬	-	-	1件: 63 💬
70	Avxs-101 (previously known as scaav9.cb.smn)	-	-	-	-	1件:  3  💬
71	Azathioprine/prednisone	Azathioprine	3件: D00238, D00473, D03033 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 85 💬
72	Azd4017 and prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 75 💬
73	Bacteriophage preparation	-	-	-	-	1件: 96 💬
74	Bascial prescription plus or minus herbs depend on symptoms	-	-	-	-	1件: 97 💬
75	Befizal l.p. 400 mg, comprimé enrobé à libération prolongée	-	-	-	-	1件: 94 💬
76	Behavioral: 6 months weight resistance and balance program	Isoxaflutole	-	-	-	1件: 13 💬
77	Behavioral: administration of probiotic (l. rhamnosus and l. acidophilus)	Lactobacillus acidophilus	1件: D04349 💬	-	-	1件: 97 💬
78	Behavioral: co-op treatment protocol	-	-	-	-	1件:  6  💬
79	Behavioral: gait and balance training program	Isoxaflutole	-	-	-	1件:  6  💬
80	Behavioral: heart health educational program	-	-	-	-	1件: 49 💬
81	Behavioral: protein and calorie controlled diet	-	-	-	-	1件: 251 💬
82	Betamethasone	Betamethasone	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	6件:  2 , 28, 46, 90, 96, 235 💬
83	Betamethasone acibutate	Betamethasone	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
84	Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days	Acetate	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件:  2  💬
85	Bi 695501 prefilled syringe	-	-	-	-	1件: 46 💬
86	Biib019 (daclizumab high yield process)	Daclizumab	1件: D03639 💬	1件: IL2RA 💬	11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 13 💬
87	Biib041 (pr fampridine)	Dalfampridine	1件: D04127 💬	4件: KCNA4, KCNC3, KCND2, KCND3 💬	4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	1件: 13 💬
88	Bio-25 probiotic	-	-	-	-	1件: 299 💬
89	Biosimilar product to adalimumab	Adalimumab	1件: D02597 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
90	Bladder instillation with heparin/ lidocaine	Heparin	4件: D00358, D02086, D07510, D08127 💬	6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬	4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction	1件: 226 💬
91	Bladder instillation with triamcinolone acetonide	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 226 💬
92	Bladder instillation without triamcinolone acetonide	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 226 💬
93	Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)	Digoxin	13件: D00298, D00330, D00455, D00529, D00550, D00696, D01207, D01475, D02290, D05028, D05259, D05261, D08229 💬	25件: ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬	49件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
94	Bortezomib/dexamethasone	Bortezomib	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 283 💬
95	Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone	Bortezomib	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 28 💬
96	Botox 100 unites allergan (pr1)	-	-	-	-	1件:  2  💬
97	Btt1023 iv infusion 20 mg/ml, 5 ml drug product	-	-	-	-	1件: 94 💬
98	Budesonide 6 mg capsules, hard (bux-pvii prototype)	Budesonide	1件: D00246 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
99	Budesonide 6 mg prolonged-release capsule, hard (bux-pvii prototype)	Budesonide	1件: D00246 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
100	Budesonide 6 mg prolonged-release capsules, hard (bux-pvii prototype)	Budesonide	1件: D00246 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
101	Budesonide 9 mg capsules, hard (bux-pvii prototype)	Budesonide	1件: D00246 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
102	Budesonide 9 mg prolonged-release capsule, hard (bux-pvii prototype)	Budesonide	1件: D00246 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
103	Budesonide 9 mg prolonged-release capsules, hard (bux-pvii prototype)	Budesonide	1件: D00246 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
104	Budesonide plus prevacid	Budesonide	1件: D00246 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 98 💬
105	Bupivacaine/epinephrine/dexamethasone	Bupivacaine	14件: D00095, D00292, D00975, D00996, D01450, D01510, D01615, D01632, D01948, D02149, D02174, D02591, D02592, D07552 💬	15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 96 💬
106	Buprenorphine	Buprenorphine	2件: D00836, D07132 💬	2件: OPRK1, OPRM1 💬	3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	2件: 46, 70 💬
107	Buprenorphine transdermal patch	Buprenorphine	2件: D00836, D07132 💬	2件: OPRK1, OPRM1 💬	3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	1件: 46 💬
108	Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf	Busulfan	8件: D00107, D00142, D00248, D01907, D02115, D03235, D07966, D08556 💬	9件: CSF3R, DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬	46件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 60 💬
109	Bydureon 2 mg powder and solvent for prolonged-release suspension	-	-	-	-	1件:  6  💬
110	C326, il-6 inhibitory avimer protein	-	-	-	-	1件: 96 💬
111	Calcium carbonate	Calcium	2件: D00932, D10802 💬	-	-	8件: 13, 19, 46, 53, 75, 96, 235, 299 💬
112	Calcium carbonate and alphacalcidol	Calcium	2件: D00932, D10802 💬	-	-	1件: 235 💬
113	Calcium carbonate d	Calcium	2件: D00932, D10802 💬	-	-	1件: 53 💬
114	Calcium lactate	Calcium	2件: D00936, D02254 💬	-	-	1件: 235 💬
115	Canakinumab (proposed)	Canakinumab	1件: D09315 💬	1件: IL1B 💬	42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection	1件: 46 💬
116	Cardiovascular profile	-	-	-	-	1件: 113 💬
117	Caveolin-1-scaffolding-protein-derived peptide (lti-03)	-	-	-	-	1件: 85 💬
118	Cd34+ enriched, t cell depleted donor stem cell product	-	-	-	-	1件: 326 💬
119	Certolizumab pegol (cdp870, tradename cimzia)(prefilled syringes at the dose of 200mg)	Certolizumab pegol	1件: D03441 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
120	Cgmp protein	-	-	-	-	1件: 97 💬
121	Chinese herb prescription granule plus prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
122	Cipro (ciprofloxacin, bayq3939)	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
123	Ciprofloxacin	Ciprofloxacin	2件: D00186, D02216 💬	-	-	5件:  2 , 60, 96, 97, 299 💬
124	Ciprofloxacin (bayq3939) dry powder for inhalation	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
125	Ciprofloxacin (cipro inhale, bayq3939)	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
126	Ciprofloxacin (cipro, bayq3939)	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
127	Ciprofloxacin (ciproxin)	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
128	Ciprofloxacin dispersion for inhalation	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
129	Ciprofloxacin dpi	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
130	Ciprofloxacin dpi (bayq3939)	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
131	Ciprofloxacin for inhalation	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
132	Ciprofloxacin hydrochloride	Ciprofloxacin	2件: D00186, D02216 💬	-	-	2件: 96, 299 💬
133	Ciprofloxacin hydrochloride monohydrate	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
134	Ciprofloxacin inhale	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
135	Circadin 2 mg comprimidos de liberación prolongada	-	-	-	-	1件: 90 💬
136	Cis-4-hydroxy-l-proline	Proline	1件: D00035 💬	-	-	1件: 94 💬
137	Cisapride	Cisapride	2件: D00274, D02092 💬	3件: HTR2A, HTR3A, HTR4 💬	7件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway	1件: 13 💬
138	Clartihromycin, amoxicillin, and omeprazole	Amoxicillin	7件: D00229, D00455, D01207, D02925, D05259, D05261, D07452 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件:  6  💬
139	Clobetasol propionate	Clobetasol	2件: D01272, D07715 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 46, 162 💬
140	Clobetasol propionate + methotrexate	Clobetasol	4件: D00142, D01272, D02115, D07715 💬	3件: DHFR, DHFR2, NR3C1 💬	6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate	1件: 162 💬
141	Clobetasol propionate alone	Clobetasol	2件: D01272, D07715 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 162 💬
142	Clobetasol propionate cream treatment	Clobetasol	2件: D01272, D07715 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 162 💬
143	Coenzyme q10 and lisinopril	Lisinopril	3件: D00362, D01065, D08131 💬	1件: ACE 💬	6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system	1件: 113 💬
144	Colal pred	-	-	-	-	1件: 97 💬
145	Colal-pred	-	-	-	-	1件: 97 💬
146	Colal-pred®	-	-	-	-	1件: 97 💬
147	Colistimethate sodium (promixin)	Colistimethate	1件: D02049 💬	-	-	1件: 299 💬
148	Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine	Azathioprine	12件: D00238, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994, D03033 💬	2件: MS4A1, NR3C1 💬	2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	1件: 35 💬
149	Combination oral budesonide and rectal hydrocortisone	Budesonide	2件: D00088, D00246 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
150	Combination product (natpara) and drug or supplements [disease and drug registry]	-	-	-	-	1件: 235 💬
151	Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi)	-	-	-	-	1件: 86 💬
152	Combination product: active treatment with dual therapy	-	-	-	-	1件:  2  💬
153	Combination product: beclomethasone dipropionate in addition to mc-evoo	Beclomethasone dipropionate	2件: D00689, D07495 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
154	Combination product: beclomethasone dipropionate in addition to refined oil	Beclomethasone dipropionate	2件: D00689, D07495 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
155	Combination product: belimumab	Belimumab	1件: D03068 💬	1件: TNFSF13B 💬	4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis	1件: 49 💬
156	Combination product: goldic serum	-	-	-	-	1件: 70 💬
157	Combination product: hyperbaric oxygen therapy-	Oxygen	1件: D00003 💬	-	-	1件: 226 💬
158	Combination product: implantable system for remodulin (treprostinil)	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
159	Combination product: l-dopa 140 mg	Levodopa	1件: D00059 💬	5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
160	Combination product: l-dopa 35 mg	Levodopa	1件: D00059 💬	5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
161	Combination product: l-dopa 70mg	Levodopa	1件: D00059 💬	5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
162	Combination product: l-dopa 70mg/carbidopa 7mg	Carbidopa	2件: D00059, D00558 💬	6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬	16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway	1件:  6  💬
163	Combination product: mavrilimumab	Mavrilimumab	1件: D09930 💬	1件: CSF2RA 💬	4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer	1件: 41 💬
164	Combination product: methotrexate	Methotrexate	2件: D00142, D02115 💬	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	1件: 46 💬
165	Combination product: nd0612 solution for sc infusion	-	-	-	-	1件:  6  💬
166	Combination product: ofatumumab with ai	Ofatumumab	1件: D09314 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	1件: 13 💬
167	Combination product: ofatumumab with prf	Ofatumumab	1件: D09314 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	1件: 13 💬
168	Combination product: prp combined magnovision	-	-	-	-	1件: 90 💬
169	Combination product: transcon pth	-	-	-	-	1件: 235 💬
170	Combination product: treprostinil via implanted pump	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
171	Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator	Acetate	2件: D00088, D00165 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
172	Combination therapy with vigabatrin and prednisolone	Prednisolone	9件: D00472, D00535, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	2件: ABAT, NR3C1 💬	8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件: 145 💬
173	Continuation of current haart (boosted protease inhibitor [pi] combination + 2 nrtis)	-	-	-	-	1件: 265 💬
174	Control intervention (no dexamethasone)	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
175	Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)	Acetate	21件: D00088, D00292, D00472, D00473, D00973, D00975, D00980, D00981, D00982, D01239, D01510, D01615, D01632, D01948, D01998, D02156, D02174, D02591, D02592, D03301, D07749 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
176	Copaxone - 20 mg/ml soluzione iniettabile in siringhe preriempite 30 siringhe	-	-	-	-	1件: 13 💬
177	Copaxone - 40 mg/ml soluzione iniettabile in siringa preriempita 12 siringhe preriempite da 1 ml con ago	-	-	-	-	1件: 13 💬
178	Copaxone 20 mg/ml solución inyectable en jeringa precargada	-	-	-	-	1件: 13 💬
179	Copaxone 20 mg/ml solución para inyección en jeringa precargada	-	-	-	-	1件: 13 💬
180	Copaxone 20 mg/ml solution for injection, pre-filled syringe	-	-	-	-	1件: 13 💬
181	Copaxone 20 mg/ml, solution for injection, pre-filled syringes	-	-	-	-	1件: 13 💬
182	Copaxone 20mg/ml solution for injection, pre-filled syringe	-	-	-	-	1件: 13 💬
183	Copaxone 40 mg/ml solution for injection, pre-filled syringe	-	-	-	-	1件: 13 💬
184	Cortef (hydrocortisone)	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 83 💬
185	Corticosteroid (prednisolone)	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 85 💬
186	Corticosteroid treatment (methylprednisolone or prednisolone)	Methylprednisolone	14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 64 💬
187	Corticosteroids (prednisone or prednisolone)	Prednisolone	9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 49 💬
188	Current marketed flolan (epoprostenol sodium)	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
189	Cyclo[l-alanyl-l-seryl-l-isoleucyl-l-prolyl-l-prolyl-l-glutaminyl-l-lysyl-l-tyrosyl-d-prolyl-l-prolyl-(2s)-2-aminodecanoyl-l-alpha-glutamyl-l-threonyl]	-	-	-	-	1件: 299 💬
190	Cyclophosphamide + pred	Cyclophosphamide	2件: D00287, D07760 💬	-	-	1件: 283 💬
191	Cyclophosphamide, azathioprine,prednisone,methylprednisolone	Azathioprine	11件: D00238, D00287, D00407, D00473, D00751, D00979, D03033, D05000, D05001, D05002, D07760 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 42, 43, 45 💬
192	Cyclophosphamide, bortezomib, and dexamethasone (cybord)	Bortezomib	12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 28 💬
193	Cyclophosphamide, bortezomib, dexamethasone	Bortezomib	12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 28 💬
194	Cyclophosphamide, bortezomib, dexamethasone plus daratumumab	Bortezomib	13件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760, D10777 💬	3件: CD38, NR3C1, PSMB5 💬	16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia	1件: 28 💬
195	Cyclophosphamide-prednisone-azathioprine	Azathioprine	5件: D00238, D00287, D00473, D03033, D07760 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 49 💬
196	Cyclosporin, methotrexate (gvhd prophylaxis)	Cyclosporine	3件: D00142, D00184, D02115 💬	7件: DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 326 💬
197	Cyclosporine oral product	Cyclosporine	1件: D00184 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 60 💬
198	D-proline	D-Proline	1件: D00035 💬	-	-	1件: 97 💬
199	D.3.2 product code where applicable13:	-	-	-	-	1件: 193 💬
200	Dabigatran etexilate	Dabigatran	2件: D07144, D09707 💬	1件: F2 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton	1件: 51 💬
201	Daclizumab high yield process	Daclizumab	1件: D03639 💬	1件: IL2RA 💬	11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 13 💬
202	Decortin (prednisona) 5 mg comprimidos	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
203	Denosumab	Denosumab	1件: D03684 💬	1件: TNFSF11 💬	7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis	7件: 46, 50, 93, 95, 96, 274, 299 💬
204	Denosumab - - immunoglobulin g2 human monoclonal antibody to rank ligand	Denosumab	1件: D03684 💬	1件: TNFSF11 💬	7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis	1件: 274 💬
205	Denosumab - immunoglobulin g2 human monoclonal antibody to rank ligand	Denosumab	1件: D03684 💬	1件: TNFSF11 💬	7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis	1件: 274 💬
206	Device: abatacept combination product (acp)	Abatacept	1件: D03203 💬	2件: CD80, CD86 💬	12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis	1件: 46 💬
207	Device: avonex prefilled syringe via manual im injection	-	-	-	-	1件: 13 💬
208	Device: biib017 (peginterferon beta-1a) pre-filled syringe (pfs)	Peginterferon beta-1a	1件: D10483 💬	2件: IFNAR1, IFNAR2 💬	18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway	1件: 13 💬
209	Device: blood pressure	-	-	-	-	1件: 84 💬
210	Device: cell processing for tcrabeta+/cd19+ depletion	-	-	-	-	1件: 65 💬
211	Device: cell processing for tcraß+/cd19+ depletion	-	-	-	-	1件: 65 💬
212	Device: cic using lofric primo	-	-	-	-	1件: 13 💬
213	Device: dexamethasone injection	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 90 💬
214	Device: heparin-induced extracorporeal ldl precipitation	Heparin	1件: D07510 💬	1件: SERPINC1 💬	1件: Complement and coagulation cascades	1件: 79 💬
215	Device: iowa oral pressure instrument	-	-	-	-	1件:  2  💬
216	Device: micro mouth pressure meter	-	-	-	-	1件:  2  💬
217	Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation	Oxygen	1件: D00003 💬	-	-	1件: 299 💬
218	Device: positive expiratory pressure	-	-	-	-	1件: 299 💬
219	Device: pre-filled syringe (pfs)	-	-	-	-	1件: 46 💬
220	Device: primus fgti (flexible great toe implant)	Florasulam	-	-	-	1件: 46 💬
221	Device: propofol dosage	Propofol	1件: D00549 💬	16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction	1件: 84 💬
222	Device: reciprocating procedure device (rpd) - avanca re no. 1091001	-	-	-	-	1件: 46 💬
223	Device: single-use autoinjector with a prefilled liquid avonex syringe	-	-	-	-	1件: 13 💬
224	Device: the ozone generator device (human pro medic, german)	Ozone	-	-	-	1件: 51 💬
225	Dexamethasone	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
226	Dexamethasone (1 cycle)	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 63 💬
227	Dexamethasone (4 cycles)	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 63 💬
228	Dexamethasone (50mg 1dd6, 3 consecutive days/month)	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 35 💬
229	Dexamethasone 0,1 mg tablets	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
230	Dexamethasone 0,5mg	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 84 💬
231	Dexamethasone 0.5mg tablet	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
232	Dexamethasone 0.5mg/5ml solution	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 35, 162 💬
233	Dexamethasone 0.5mg/5ml solution in mucolox™	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 35, 162 💬
234	Dexamethasone 1,5 mg tablets	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
235	Dexamethasone 21-dihydrogen phosphate	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 65 💬
236	Dexamethasone 21-phosphate	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
237	Dexamethasone 2mg tablets	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
238	Dexamethasone 4 mg jenapharm	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 28 💬
239	Dexamethasone abcur	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 63 💬
240	Dexamethasone and rituximab	Dexamethasone	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994 💬	2件: MS4A1, NR3C1 💬	2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	1件: 63 💬
241	Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland).	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 235 💬
242	Dexamethasone parotid irrigation	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 53 💬
243	Dexamethasone sodium phosphate	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 65, 70, 96 💬
244	Dexamethasone sodium phosphate 250 mg/ 10 ml	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 96 💬
245	Dexamethasone sodium phosphate 250 mg/10 ml solution	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 299 💬
246	Dexamethasone sodium phosphate ph. eur.	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 65 💬
247	Dexamethasone sodium sulfate	Dexamethasone	11件: D00292, D00975, D01510, D01615, D01632, D01732, D01948, D02174, D02591, D02592, D05877 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 28 💬
248	Dexamethasone soduim phosphate	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
249	Dexamethasone, 40 mg	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 28 💬
250	Dexmedetomidine	Dexmedetomidine	2件: D00514, D01205 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
251	Dexmedetomidine 1	Dexmedetomidine	2件: D00514, D01205 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	1件: 280 💬
252	Dexmedetomidine 2	Dexmedetomidine	2件: D00514, D01205 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	1件: 280 💬
253	Dexmedetomidine 3	Dexmedetomidine	2件: D00514, D01205 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	1件: 280 💬
254	Dexmedetomidine group	Dexmedetomidine	2件: D00514, D01205 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	1件: 70 💬
255	Dexmedetomidine hydrochloride	Dexmedetomidine	2件: D00514, D01205 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	1件: 70 💬
256	Dexmedetomidine hydrochloride infusion	Dexmedetomidine	2件: D00514, D01205 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	1件:  6  💬
257	Dexmedetomidine with ropivacaine	Dexmedetomidine	4件: D00514, D01205, D04048, D08490 💬	8件: ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway	1件: 70 💬
258	Diagnostic test: beam test to predict falls	Tricyclazole	-	-	-	1件:  6  💬
259	Diagnostic test: biotherapy prescription with sinnotest® software	-	-	-	-	1件: 46 💬
260	Diagnostic test: dexamethasone test	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 75 💬
261	Diagnostic test: fecal microbiome probiotic	-	-	-	-	1件: 294 💬
262	Diagnostic test: preoparative blood laboratory tests	-	-	-	-	1件: 235 💬
263	Diagnostic test: pressure pain threshold	-	-	-	-	1件: 113 💬
264	Diagnostic test: pulmonary microbiome probiotic	-	-	-	-	1件: 294 💬
265	Diagnostic test: retrospective evaluation of endoscopy prior to study drug	-	-	-	-	1件: 98 💬
266	Diagnostic test: voc probiotic	-	-	-	-	1件: 294 💬
267	Diazoxide	Diazoxide	1件: D00294 💬	2件: ABCC8, KCNJ11 💬	4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus	2件: 13, 193 💬
268	Diazoxide choline	Choline	2件: D00294, D07690 💬	2件: ABCC8, KCNJ11 💬	4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus	1件: 193 💬
269	Diazoxide choline controlled-release tablet	Choline	2件: D00294, D07690 💬	2件: ABCC8, KCNJ11 💬	4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus	1件: 193 💬
270	Diclofenac + omeprazole	Diclofenac	7件: D00455, D00903, D00904, D01207, D05259, D05261, D07816 💬	4件: ATP4A, ATP4B, PTGS1, PTGS2 💬	26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 46 💬
271	Dimebon + omeprazole	Latrepirdine	5件: D00455, D01207, D05259, D05261, D09917 💬	8件: ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬	26件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway	1件:  8  💬
272	Dopamine agonists (pramipexole, ropirinole)	Dopamine	4件: D00559, D00633, D05575, D07870 💬	5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
273	Dose of 60 mg/kg alpha1-proteinase inhibitor	Alpha-1-proteinase inhibitor	-	-	-	1件: 231 💬
274	Dose of 60 mg/kg fraction iv-1 alpha1-proteinase inhibitor	Alpha-1-proteinase inhibitor	-	-	-	1件: 231 💬
275	Doxepin	Doxepin	2件: D00814, D07875 💬	3件: HRH1, SLC6A2, SLC6A4 💬	5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	1件:  6  💬
276	Doxepin and zopiclone	Doxepin	3件: D00814, D01372, D07875 💬	19件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬	10件: Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction	1件:  6  💬
277	Dual release hydrocortisone (plenadren)	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
278	Dupilumab prefilled syringe	Dupilumab	1件: D10354 💬	1件: IL4R 💬	8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation	1件: 160 💬
279	Egg white protein	Egg	-	-	-	1件: 96 💬
280	Egg yolk preparation with cholesterol	Cholesterol	1件: D00040 💬	-	-	1件: 310 💬
281	Eltrombopag	Eltrombopag	1件: D03978 💬	-	-	5件: 60, 63, 65, 284, 285 💬
282	Eltrombopag (revolade)	Eltrombopag	1件: D03978 💬	-	-	1件: 63 💬
283	Eltrombopag 12.5 mg	Eltrombopag	1件: D03978 💬	-	-	1件: 60 💬
284	Eltrombopag 25 mg	Eltrombopag	1件: D03978 💬	-	-	1件: 60 💬
285	Eltrombopag combining rituximab	Eltrombopag	2件: D02994, D03978 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	1件: 63 💬
286	Eltrombopag olamine	Eltrombopag	1件: D03978 💬	-	-	2件: 60, 63 💬
287	Eltrombopag olamine (sb-497115-gr)	Eltrombopag	1件: D03978 💬	-	-	1件: 63 💬
288	Eltrombopag olamine, revolade, promacta	Eltrombopag	1件: D03978 💬	-	-	1件: 63 💬
289	Eltrombopag oral tablets	Eltrombopag	1件: D03978 💬	-	-	1件: 63 💬
290	Enbrel - 50 mg soluzione iniettabile in siringa (vetro da 1 ml) preriempita - uso sottocutaneo 12 siringhe preriempite + 24 tamponi imbevuti di alcol	-	-	-	-	1件: 46 💬
291	Enbrel 50 mg solution for injection in pre-filled syringe	-	-	-	-	1件: 46 💬
292	Enbrel 50mg pre-filled pen	-	-	-	-	1件: 46 💬
293	Enbrel 50mg pre-filled syringe	-	-	-	-	1件: 46 💬
294	Enbrel pre-filled pen	-	-	-	-	1件: 46 💬
295	Enbrel pre-filled syringe	-	-	-	-	1件: 46 💬
296	Enbrel® 50 mg solution for injection in pre-filled syringe	-	-	-	-	1件: 46 💬
297	Engineerd protein inhibitor of human neutrophil elastase	-	-	-	-	1件: 299 💬
298	Engineered protein inhibitor of human neutrophil elastase	-	-	-	-	1件: 299 💬
299	Ensure high protein	-	-	-	-	1件: 299 💬
300	Epinephrine	Epinephrine	3件: D00095, D00996, D02149 💬	9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬	13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	2件: 46, 96 💬
301	Epoprostenol	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
302	Epoprostenol for injection	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
303	Epoprostenol sodico	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
304	Epoprostenol sodium	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
305	Epoprostenol-actelion	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
306	Erythromycin	Erythromycin	9件: D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054 💬	-	-	5件:  6 , 36, 164, 228, 291 💬
307	Erythropoietin	Erythropoietin	1件: D03231 💬	1件: EPOR 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	9件:  2 ,  6 , 13, 18, 22, 47, 70, 95, 96 💬
308	Erythropoietin human recombinant (eporh)	Erythropoietin	1件: D03231 💬	1件: EPOR 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	1件:  6  💬
309	Etanercept pre-filled syringe	Etanercept	1件: D00742 💬	2件: LTA, TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
310	Etanercept pre-filled syringe sq injection	Etanercept	1件: D00742 💬	2件: LTA, TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
311	Etanercept, methotrexate, prednisolone	Etanercept	11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬	5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬	70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 56 💬
312	Eus procedure with drug injection	-	-	-	-	1件: 298 💬
313	Evaluation of biological predictive factors of clinical response to ustekinumab	Ustekinumab	1件: D09214 💬	3件: IL12A, IL12B, IL23A 💬	26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus	1件: 96 💬
314	Everolimus oral product	Everolimus	1件: D02714 💬	1件: MTOR 💬	50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway	2件: 89, 158 💬
315	Exelon patch (rivastigmine transdermal system)	Rivastigmine	2件: D02558, D03822 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	1件:  6  💬
316	Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14)	-	-	-	-	1件: 13 💬
317	Fampyra 10 mg prolonged-release tablets	-	-	-	-	1件: 13 💬
318	Fampyra 10mg prolonged release tablets	-	-	-	-	1件: 13 💬
319	Fentanyl (low dose) + dexmedetomidine	Dexmedetomidine	4件: D00320, D00514, D01205, D01399 💬	4件: ADRA2A, ADRA2B, ADRA2C, OPRM1 💬	4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	1件: 215 💬
320	Finasteride	Finasteride	1件: D00321 💬	1件: SRD5A2 💬	2件: Prostate cancer, Steroid hormone biosynthesis	1件:  6  💬
321	Fixed dose combination ciprofloxacin/celecoxib	Celecoxib	3件: D00186, D00567, D02216 💬	1件: PTGS2 💬	22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件:  2  💬
322	Fluconazole	Fluconazole	2件: D00322, D01429 💬	-	-	2件: 96, 225 💬
323	Fluoxetine	Fluoxetine	2件: D00326, D00823 💬	1件: SLC6A4 💬	2件: Serotonergic synapse, Synaptic vesicle cycle	4件: 13, 17, 78, 86 💬
324	Fluoxetine hydrochloride	Fluoxetine	2件: D00326, D00823 💬	1件: SLC6A4 💬	2件: Serotonergic synapse, Synaptic vesicle cycle	1件: 13 💬
325	Fluticasone propionate	Fluticasone	2件: D01708, D07981 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 98, 228 💬
326	Fluticasone propionate, 800 mcg twice daily (post 4fed failure)	Fluticasone	2件: D01708, D07981 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 98 💬
327	Fluticasone propionate, 880 mcg twice daily (after 6fed failure)	Fluticasone	2件: D01708, D07981 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 98 💬
328	Fluticasone propionate, usp	Fluticasone	2件: D01708, D07981 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 98 💬
329	Freshly-pressed extra virgin olive oil	Olea europaea leaf	1件: D03311 💬	-	-	1件: 13 💬
330	G2-sfm (ifn-beta-1a from clone 484-39,fbs-free process)	-	-	-	-	1件: 13 💬
331	Gabapentin prescriptions	Gabapentin	1件: D00332 💬	5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬	9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle	1件: 298 💬
332	Gadoteridol	Gadoteridol	1件: D01137 💬	-	-	1件: 13 💬
333	Gadovist 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado	-	-	-	-	1件: 13 💬
334	Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one)	Ganaxolone	1件: D04300 💬	16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction	1件: 152 💬
335	Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one)	Ganaxolone	1件: D04300 💬	16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction	1件: 152 💬
336	Genetic: protein expression analysis	-	-	-	-	2件: 28, 60 💬
337	Genetically engineered hematopoietic stem progenitor cells	-	-	-	-	1件: 285 💬
338	Genetically engineered hematopoietic stem/progenitor cells	-	-	-	-	1件: 285 💬
339	Glucocorticoid (prednisone or prednisolone)	Prednisolone	9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 84 💬
340	Glycomacropeptide-based protein substitute	-	-	-	-	1件: 240 💬
341	Golimumab final vialed product (fvp)	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
342	Golimumab liquid in prefilled pen	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
343	Golimumab liquid in prefilled pen or prefilled syringe	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
344	Golimumab liquid in prefilled syringe	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	3件: 46, 84, 97 💬
345	Golimumab pre-filled syringe	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	2件: 46, 271 💬
346	Golimumab prefilled pen	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
347	Golimumab prefilled pen or prefilled syringe	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
348	Golimumab prefilled syringe	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 97 💬
349	Gp2013 - a proposed biosimilar rituximab	Rituximab	1件: D02994 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	1件: 46 💬
350	Granulocyte-colony stimulating factor (g-csf) and prednisone	Filgrastim	2件: D00473, D03235 💬	2件: CSF3R, NR3C1 💬	6件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer	1件: 13 💬
351	Group a sle prospective study	-	-	-	-	1件: 49 💬
352	Gsk1605786 gsk modified-process: formulation d	-	-	-	-	1件: 96 💬
353	Gvhd prophylaxis	-	-	-	-	2件: 60, 65 💬
354	Heparin & alkalinized lidocaine bladder instillation	Heparin	4件: D00358, D02086, D07510, D08127 💬	6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬	4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction	1件: 226 💬
355	Hepatitis b virus surface antigen recombinant (s protein)	-	-	-	-	1件: 46 💬
356	Heterologous human adult liver-derived progenitor cells	-	-	-	-	1件: 251 💬
357	Heterologous human adult liver-derived progenitor cells (hhalpc)	-	-	-	-	1件: 251 💬
358	High dose dexamethasone pulses	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 63 💬
359	High protein high fiber diet	-	-	-	-	2件: 93, 95 💬
360	High protein. t-diet plus range	-	-	-	-	1件:  6  💬
361	Hormonal profile	-	-	-	-	1件: 113 💬
362	Hormone (prednisone)	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
363	Hpv prophylactic vaccine gardasil	-	-	-	-	1件: 49 💬
364	Human anti-promyostatin monoclonal antibody	-	-	-	-	1件:  3  💬
365	Human glucocerebrosidase (prgcd)	Taliglucerase alfa	1件: D09675 💬	1件: GBA 💬	4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism	1件: 19 💬
366	Human monoclonal antibody directed against complement 5 protein	-	-	-	-	1件: 62 💬
367	Human primary retinal pigment epithelial (hurpe) cells	-	-	-	-	1件: 90 💬
368	Human recombinant tissue non-specific alkaline phosphatase fusion protein	Alkaline Phosphatase	-	-	-	1件: 172 💬
369	Human retinal progenitor cells	-	-	-	-	1件: 90 💬
370	Human retinal progenitor cells drug product	-	-	-	-	1件: 90 💬
371	Humira 20 mg solution for injection in pre-filled syringe	-	-	-	-	1件: 96 💬
372	Humira 40 mg injekcní roztok v predplnené injekcní stríkacce	-	-	-	-	1件: 96 💬
373	Humira 40 mg solución inyectable en jeringa precargada	-	-	-	-	2件: 46, 96 💬
374	Humira 40 mg solution for injection in pre-filled pen	-	-	-	-	1件: 96 💬
375	Humira 40 mg solution for injection in pre-filled syringe	-	-	-	-	3件: 46, 96, 97 💬
376	Humira 40 mg solution for injection in pre-filled syringes	-	-	-	-	1件: 97 💬
377	Humira 40mg solution for injection in pre-filled syringe	-	-	-	-	1件: 46 💬
378	Humira 40mg solution for injection in pre-filled syringe (adalimumab)	Adalimumab	1件: D02597 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
379	Humira 40mg/0.4ml pre-filled syringe	-	-	-	-	1件: 96 💬
380	Humira 40mg/0.8ml solution for injection in pre-filled syringe	-	-	-	-	1件: 46 💬
381	Humira pre-filled pen	-	-	-	-	1件: 96 💬
382	Humira ® (adalimumab) 40mg/0.8ml pre-filled syringe	Adalimumab	1件: D02597 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
383	Humira, 40 mg solution for injection in pre-filled syringe	-	-	-	-	1件: 46 💬
384	Humira® 40 mg solution for injection in pre-filled syringe	-	-	-	-	1件: 46 💬
385	Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe	-	-	-	-	1件: 46 💬
386	Hydrocortisone	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	9件:  6 , 46, 53, 75, 78, 81, 83, 97, 299 💬
387	Hydrocortisone (solucortef)	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
388	Hydrocortisone 100mg/ml	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 83 💬
389	Hydrocortisone 10mg	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
390	Hydrocortisone 10mg tablet	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
391	Hydrocortisone 10mg tablets	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
392	Hydrocortisone 20mg tablets	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
393	Hydrocortisone acetate	Acetate	2件: D00088, D00165 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
394	Hydrocortisone cream	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件:  6  💬
395	Hydrocortisone cream 1%	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件:  6  💬
396	Hydrocortisone cream 10mg/g fna fagron	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件:  6  💬
397	Hydrocortisone hydrogen succinate	Hydrocortisone	2件: D00088, D01442 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 83 💬
398	Hydrocortisone modified release capsules	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
399	Hydrocortisone roussel	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 83 💬
400	Hydrocortisone sodium acetate	Acetate	2件: D00088, D01779 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
401	Hydrocortisone sodium phosphate	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 53, 81, 83 💬
402	Hydrocortisone sodium succinate	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 81, 83, 97 💬
403	Hydrocortisone tablet 2.5 mg	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
404	Hydrocortisone takeda, tabletter	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 78 💬
405	Hydroxychloroquine + prednisone	Hydroxychloroquine	2件: D00473, D08050 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 84 💬
406	Imd preparative regimen	-	-	-	-	5件: 19, 20, 125, 234, 326 💬
407	Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy	-	-	-	-	1件:  2  💬
408	Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy chain), disulfide with human mus musculus monoclonal light chain, dimer	-	-	-	-	1件:  2  💬
409	Inactive reminder product	-	-	-	-	1件: 19 💬
410	Inflammatory profile	-	-	-	-	1件: 113 💬
411	Inhaled prostacyclin	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
412	Inn not yet proposed	-	-	-	-	1件: 193 💬
413	Interferon beta-1a (current approved manufacturing process invloving fbs)	Human interferon beta	1件: D04554 💬	2件: IFNAR1, IFNAR2 💬	18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway	1件: 13 💬
414	Interferon beta-1a (new process, manufactured without fbs)	Human interferon beta	1件: D04554 💬	2件: IFNAR1, IFNAR2 💬	18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway	1件: 13 💬
415	Interferon beta-1b and tacrolimus	Human interferon beta	3件: D00107, D00746, D08556 💬	7件: IFNAR1, IFNAR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	47件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 13 💬
416	Interleukin-2 (aldesleukin).	Aldesleukin	1件: D00748 💬	3件: IL2RA, IL2RB, IL2RG 💬	14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor	2件: 96, 97 💬
417	Intervention for incipient patients at low risk of disease progression	-	-	-	-	1件: 66 💬
418	Intervention for patients at high risk of disease progression	-	-	-	-	1件: 66 💬
419	Intra plexus triamcinolone and bupivicaine injection	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 298 💬
420	Intra-articular compound betamethasone	Betamethasone	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
421	Intraarticular betamethasone	Betamethasone	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
422	Intraarticular dexamethasone	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
423	Intravenous dexamethasone 1 mg	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
424	Intravenous methyl prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 43 💬
425	Intubated with propofol (ip)	Propofol	1件: D00549 💬	16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction	1件: 98 💬
426	Ir prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
427	Ivacaftor (proposed inn)	Ivacaftor	1件: D09916 💬	1件: CFTR 💬	8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway	1件: 299 💬
428	Kenalog injectable product	-	-	-	-	1件: 70 💬
429	Kinoquinone (proposed)	-	-	-	-	1件:  6  💬
430	L-lysyl-d-prolyl-l-threonine acetate	Acetate	1件: D00041 💬	-	-	1件: 97 💬
431	L-lysyl-d-prolyl-lthreonine acetate, lyophilisate	Acetate	-	-	-	1件: 97 💬
432	L01xe - protein kinase inhibitors	-	-	-	-	1件: 85 💬
433	Lactic acid producing organisms	Lactic acid	1件: D00111 💬	-	-	1件: 299 💬
434	Lamotrigine - generic product	Lamotrigine	1件: D00354 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	1件: 38 💬
435	Lansoprazole	Lansoprazole	1件: D00355 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	7件: 63, 71, 85, 98, 166, 222, 299 💬
436	Lansoprazole 30mg	Lansoprazole	1件: D00355 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 166 💬
437	Lansoprazole, amoxicillin, clarithromycin	Amoxicillin	5件: D00229, D00276, D00355, D02925, D07452 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 222 💬
438	Lansoprazole, clarithromycin, amoxycillin	Amoxicillin	5件: D00229, D00276, D00355, D02925, D07452 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 63 💬
439	Lantus® 100 units/ml solution for injection in a vial. lantus® 100 units/ml solution for injection in a cartridge. lantus® 100 units/ml solution for injection in a pre-filled pen	-	-	-	-	1件: 299 💬
440	Lap tap bupivacaine/epinephrine	Bupivacaine	5件: D00095, D00996, D01450, D02149, D07552 💬	14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 96 💬
441	Large protein molecule	-	-	-	-	1件: 46 💬
442	Lcp-tacro (tacrolimus)	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 95 💬
443	Leflunomide 20 mg+prednisone 0.5mg/kg/d	Leflunomide	2件: D00473, D00749 💬	2件: DHODH, NR3C1 💬	4件: Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism	1件: 66 💬
444	Lenalidomide and dexamethasone	Dexamethasone	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 16 💬
445	Lenalidomide+dexamethasone	Dexamethasone	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 16 💬
446	Lenalidomide, dexamethasone	Dexamethasone	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 16 💬
447	Lenalidomide, dexamethasone and cyclophosphamide	Cyclophosphamide	12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687, D07760 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 28 💬
448	Lenti-d drug product	-	-	-	-	1件: 20 💬
449	Letrozole	Letrozole	1件: D00964 💬	1件: CYP19A1 💬	3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis	2件: 81, 89 💬
450	Levemir 100 u/ml solution for injection in a cartridge, levemir 100 u/ml solution for injection in a pre-filled pen	-	-	-	-	1件: 299 💬
451	Levocarnitine	Levocarnitine	3件: D02030, D02176, D04713 💬	-	-	3件:  3 , 53, 97 💬
452	Levocarnitine propyl hydrochloride	Levocarnitine	3件: D02030, D02176, D04713 💬	-	-	1件: 97 💬
453	Licorice	Licorice	1件: D04365 💬	-	-	1件: 53 💬
454	Lidocaine	Lidocaine	3件: D00358, D02086, D08127 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	10件:  6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬
455	Lidocaine 1% injectable solution	Lidocaine	3件: D00358, D02086, D08127 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	1件: 34 💬
456	Lidocaine 2% without vessel constrictor	Lidocaine	3件: D00358, D02086, D08127 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	1件: 51 💬
457	Lidocaine injection 2%	Lidocaine	3件: D00358, D02086, D08127 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	1件: 168 💬
458	Lidocaine patch 5%	Lidocaine	3件: D00358, D02086, D08127 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	1件: 13 💬
459	Lidocaine releasing intravesical system - liris®	Lidocaine	3件: D00358, D02086, D08127 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	1件: 226 💬
460	Lisinopril	Lisinopril	2件: D00362, D08131 💬	1件: ACE 💬	6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system	7件: 19, 46, 49, 66, 67, 113, 222 💬
461	Lisinopril pills	Lisinopril	2件: D00362, D08131 💬	1件: ACE 💬	6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system	1件: 49 💬
462	Lisinopril, losartan, and atorvastatin	Atorvastatin	7件: D00258, D00357, D00362, D00887, D07474, D08131, D08146 💬	3件: ACE, AGTR1, HMGCR 💬	22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 222 💬
463	Local anesthesia (lidocaine hydrochloride)	Lidocaine	3件: D00358, D02086, D08127 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	1件:  6  💬
464	Lodotra (delayed release prednisolone)	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 41 💬
465	Lonafarnib, zoledronic acid, and pravastatin	Lonafarnib	7件: D00893, D01968, D04768, D06378, D06379, D08410, D08689 💬	4件: FDPS, FNTA, FNTB, HMGCR 💬	6件: AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis	1件: 333 💬
466	Long term follow up in all patients who received sar422459 in previous study tdu13583	-	-	-	-	1件: 301 💬
467	Long-circulating liposomal prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
468	Losartan and atenolol or propranolol	Atenolol	5件: D00235, D00357, D00483, D08146, D08443 💬	4件: ADRB1, ADRB2, ADRB3, AGTR1 💬	22件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 167 💬
469	Low calorie protein substitute	-	-	-	-	1件: 240 💬
470	Low dose prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 84 💬
471	Low-dose aldesleukin (proleukin®)	Aldesleukin	1件: D00748 💬	3件: IL2RA, IL2RB, IL2RG 💬	14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor	1件: 49 💬
472	Lysine-d-proline-threonine	D-Proline	3件: D00035, D00041, D02304 💬	-	-	1件: 97 💬
473	Mabthera or biosimilar rituximab product	Rituximab	1件: D02994 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	1件: 13 💬
474	Medium dose prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 84 💬
475	Melatonin pr	Melatonin	1件: D08170 💬	2件: MTNR1A, MTNR1B 💬	2件: Circadian entrainment, Neuroactive ligand-receptor interaction	1件:  6  💬
476	Melphalan, thalidomide and dexamethasone	Dexamethasone	11件: D00292, D00369, D00754, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 28 💬
477	Mesalazine with hydrocortisone sodium succinate	Hydrocortisone	2件: D00088, D00377 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
478	Mesencephalic neuronal precursor cells	-	-	-	-	1件:  6  💬
479	Metabolic profile	-	-	-	-	1件: 113 💬
480	Methotrexate (metoject® prefilled pen)	Methotrexate	2件: D00142, D02115 💬	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	1件: 46 💬
481	Methotrexate - etanercept - prednisolone arm	Etanercept	11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬	5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬	70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
482	Methotrexate 50mg/ml solution for injection, pre-filled syringe	Methotrexate	2件: D00142, D02115 💬	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	1件: 46 💬
483	Methotrexate pre-filled pen	Methotrexate	2件: D00142, D02115 💬	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	1件: 46 💬
484	Methotrexate prefilled pen	Methotrexate	2件: D00142, D02115 💬	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	1件: 46 💬
485	Methotrexate prefilled syringe	Methotrexate	2件: D00142, D02115 💬	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	1件: 46 💬
486	Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol	Methotrexate	2件: D00142, D02115 💬	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	1件: 46 💬
487	Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.	Methotrexate	2件: D00142, D02115 💬	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	1件: 46 💬
488	Methyl prednisolonate	-	-	-	-	1件: 13 💬
489	Methyl prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 43, 49, 96 💬
490	Methylene blue	Methylene blue	2件: D02312, D10537 💬	-	-	1件: 97 💬
491	Methylene blue 25mg tablets	Methylene blue	2件: D02312, D10537 💬	-	-	1件: 97 💬
492	Methylprednisolone (mp) or prednisone (pred)	Methylprednisolone	7件: D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
493	Methylprednisolone or prednisolone	Methylprednisolone	14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 65 💬
494	Metoclopramide	Metoclopramide	3件: D00726, D02213, D05008 💬	1件: DRD2 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件: 51 💬
495	Metoclopramide accord - 10 mg compresse 28 compresse in blister pvc/pvdc/al	Metoclopramide	3件: D00726, D02213, D05008 💬	1件: DRD2 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件: 51 💬
496	Metoject 10 mg/ml, solution injectable en seringue pré-remplie	-	-	-	-	1件: 44 💬
497	Mezavant gastro-resistant, prolonged release tablets	-	-	-	-	1件: 97 💬
498	Mezavant xl 1200 mg gastro-resistant prolonged release tablets	-	-	-	-	1件: 97 💬
499	Mezavant xl 1200 mg gastro-resistant, prolonged release tablets	-	-	-	-	1件: 97 💬
500	Mezavant xl 1200 mg gastro-resistant, prolonged release tablets.	-	-	-	-	1件: 97 💬
501	Mezavant xl 1200mg gastro-resistant, prolonged release tablets	-	-	-	-	1件: 97 💬
502	Mezavant xl gastro-resistant, prolonged release tablets	-	-	-	-	1件: 97 💬
503	Midodrine	Midodrine	2件: D01307, D08220 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	3件:  6 , 17, 58 💬
504	Midodrine hydrochloride	Midodrine	2件: D01307, D08220 💬	3件: ADRA1A, ADRA1B, ADRA1D 💬	7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 58 💬
505	Milrinone	Milrinone	2件: D00417, D02085 💬	2件: PDE3A, PDE3B 💬	11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 294 💬
506	Mirapex (pramipexole)	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
507	Mmf and dexamethasone	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 222 💬
508	Mobilization of stem cells to prepare for leukapheresis	-	-	-	-	1件: 96 💬
509	Modafinil	Modafinil	1件: D01832 💬	-	-	4件:  6 , 13, 49, 93 💬
510	Modafinil 50mg	Modafinil	1件: D01832 💬	-	-	1件:  6  💬
511	Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142	BMS-986142	11件: D00298, D00330, D00529, D00550, D00696, D00893, D01475, D02290, D05028, D08229, D08410 💬	24件: ATP1A1, ATP1A2, ATP1A3, ATP1A4, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HMGCR, PTGS1, PTGS2 💬	49件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
512	Moss-agal (recombinant human alpha-galactosidase a produced in moss)	Agalsidase alfa	1件: D02784 💬	1件: GLA 💬	6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism	1件: 19 💬
513	Mr prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
514	Multienzymes (lipase, protease etc.)	-	-	-	-	2件: 298, 299 💬
515	Mupirocin	Mupirocin	2件: D01076, D02195 💬	-	-	2件: 227, 299 💬
516	Mupirocin intranasal creme	Mupirocin	2件: D01076, D02195 💬	-	-	1件: 299 💬
517	Mycophenolate mofetil plus lower dose of prednisone	Mycophenolate mofetil	5件: D00473, D00752, D05094, D05095, D05096 💬	3件: IMPDH1, IMPDH2, NR3C1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism	1件: 66 💬
518	Myeloablative preparative regimen	-	-	-	-	3件: 62, 65, 284 💬
519	Myelostim - 34 1 flaconcino liofilizzato 33.6 miu + siringa preriempita solvente 1 ml	-	-	-	-	2件: 19, 65 💬
520	N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	-	-	-	-	1件: 13 💬
521	Naproxen 500 mg tablets (pn 200 minus omeprazole)	Naproxen	5件: D00118, D00455, D01207, D05259, D05261 💬	4件: ATP4A, ATP4B, PTGS1, PTGS2 💬	26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	2件: 46, 271 💬
522	Nebido® testosterone undecanoate 1000 mg/4 ml solution for injection	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	1件: 13 💬
523	Nebulized combination ipratropium bromide with salbutamol	Ipratropium	2件: D02147, D02212 💬	6件: ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	17件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
524	New thermo stable formulation of epoprostenol sodium	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
525	Nifedipine	Nifedipine	1件: D00437 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	2件: 50, 81 💬
526	Non propietry, therefore n/a	-	-	-	-	1件: 51 💬
527	Novorapid 100 u/ml, solution for injection in a vial. novorapid penfill 100 u/ml, solution for injection in a cartridge. novorapid flexpen 100 u/ml, solution for injection in a pre-filled pen.	-	-	-	-	1件: 299 💬
528	Nusinersen injectable product	Nusinersen	1件: D10881 💬	1件: SMN2 💬	1件: RNA transport	1件:  3  💬
529	Omega 3 premium	-	-	-	-	1件: 299 💬
530	Omeprazole	Omeprazole	4件: D00455, D01207, D05259, D05261 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	16件:  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
531	Omeprazole (uk licensed generic product)	Omeprazole	4件: D00455, D01207, D05259, D05261 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 85 💬
532	Omeprazole 20 mg	Omeprazole	4件: D00455, D01207, D05259, D05261 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	2件: 96, 97 💬
533	Omeprazole 20mg	Omeprazole	4件: D00455, D01207, D05259, D05261 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 51 💬
534	Omeprazole 20mg bid	Omeprazole	4件: D00455, D01207, D05259, D05261 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 98 💬
535	Omeprazole 40 mg	Omeprazole	4件: D00455, D01207, D05259, D05261 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 96 💬
536	Omeprazole 40mg capsule	Omeprazole	4件: D00455, D01207, D05259, D05261 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 299 💬
537	Omeprazole magnesium	Magnesium	4件: D00455, D01207, D05259, D05261 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 225 💬
538	Omeprazole rectally 1mg/kg	Omeprazole	4件: D00455, D01207, D05259, D05261 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 294 💬
539	Oms721 drug product 185 mg/ml	-	-	-	-	1件: 109 💬
540	Only medicinal products registered in austria will be used in this clinical trial.	-	-	-	-	1件: 78 💬
541	Only medicinal products registered in germany will be used in this clinical trial	-	-	-	-	1件: 78 💬
542	Oral ciprofloxacin	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
543	Oral ciprofloxacin plus inhaled colistin	Ciprofloxacin	4件: D00186, D02138, D02216, D07746 💬	-	-	1件: 299 💬
544	Oral erythromycin	Erythromycin	9件: D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054 💬	-	-	1件: 36 💬
545	Oral prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 49, 145 💬
546	Oral prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 251 💬
547	Oral prednisone 5mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 49 💬
548	Oral probiotic	-	-	-	-	1件: 291 💬
549	Orencia 125 mg solution for injection in pre-filled syringe	-	-	-	-	3件: 46, 49, 53 💬
550	Orencia 125 mg, solution injectable en seringue préremplie	-	-	-	-	1件: 46 💬
551	Orencia® 125 mg solution for injection in pre-filled syringe	-	-	-	-	1件: 65 💬
552	Osteopetrosis haploidentical only preparative regimen	-	-	-	-	5件: 19, 20, 125, 234, 326 💬
553	Osteopetrosis only preparative regimen	-	-	-	-	5件: 19, 20, 125, 234, 326 💬
554	Other respiratory system products	-	-	-	-	1件: 299 💬
555	Other: a-step (new protocol)	-	-	-	-	1件: 299 💬
556	Other: best practice	-	-	-	-	1件: 60 💬
557	Other: classic, progressive endurance training	-	-	-	-	1件: 13 💬
558	Other: controls primary cervical dystonia (trihexyphenidyl)	Trihexyphenidyl	2件: D00787, D08638 💬	5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway	1件:  6  💬
559	Other: empiric use of calcium carbonate and calcitriol	Calcitriol	3件: D00129, D00932, D10802 💬	1件: VDR 💬	4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis	1件: 235 💬
560	Other: eus procedure	-	-	-	-	1件: 298 💬
561	Other: glucose profile for 2 weeks	Dextrose, unspecified form	-	-	-	1件: 299 💬
562	Other: high energy / protein diet.	-	-	-	-	1件: 96 💬
563	Other: histone acetylation profiles of cells of srt patients with crebbp mutations	-	-	-	-	1件: 102 💬
564	Other: hydrocortisone	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 75 💬
565	Other: imitation surgical procedure (isp)	-	-	-	-	1件:  6  💬
566	Other: low blood pressure control	-	-	-	-	1件: 67 💬
567	Other: plasticity-based computerized cognitive remediation program	-	-	-	-	1件: 13 💬
568	Other: prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
569	Other: pretreatment antibiotics	-	-	-	-	1件: 97 💬
570	Other: progressive exercise	-	-	-	-	1件: 13 💬
571	Other: propensity score	-	-	-	-	1件: 13 💬
572	Other: prospective observational registry	-	-	-	-	1件:  3  💬
573	Other: pth based calcium carbonate and calcitriol repletion	Calcitriol	3件: D00129, D00932, D10802 💬	1件: VDR 💬	4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis	1件: 235 💬
574	Other: pulmonary rehabilitation program	-	-	-	-	1件: 85 💬
575	Other: refered to general practice	-	-	-	-	1件: 46 💬
576	Other: resistance exercise program	-	-	-	-	1件: 46 💬
577	Other: salbutamol nebulisation and with cpap	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 228 💬
578	Other: screening to prevent falls	-	-	-	-	1件:  6  💬
579	Other: sham procedure	-	-	-	-	1件: 90 💬
580	Other: sham-procedure (dose cohort 1&2 only)	-	-	-	-	2件: 90, 303 💬
581	Other: specifically design 6 month resistance training program	-	-	-	-	1件: 13 💬
582	Other: standard blood pressure control	-	-	-	-	1件: 67 💬
583	Other: standard treatment according to the clinical protocols	-	-	-	-	1件: 49 💬
584	Other: water prescription	Water	1件: D00001 💬	-	-	1件: 67 💬
585	Over encapsulated prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 41 💬
586	Over-encapsulated modafinil	Modafinil	1件: D01832 💬	-	-	1件:  6  💬
587	Overencapsulated prednisolone tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
588	Oxn 10 mg / 5 mg pr	-	-	-	-	1件:  6  💬
589	Oxn 10/5 mg pr	-	-	-	-	1件: 226 💬
590	Oxn 20 mg / 10 mg pr	-	-	-	-	1件:  6  💬
591	Oxn 20/10 mg pr	-	-	-	-	1件: 226 💬
592	Oxn 5 mg/2.5 mg pr	-	-	-	-	1件:  6  💬
593	Oxn 5/2.5 mg pr	-	-	-	-	1件: 226 💬
594	Oxycodone naloxone prolonged release tablets	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
595	Oxycodone/naloxone prolonged release t	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
596	Oxycodone/naloxone prolonged release tablets	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件:  6  💬
597	Oxycodone/naloxone prolonged release tablets 10 mg /5 mg	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件:  6  💬
598	Oxycodone/naloxone prolonged release tablets 10/5 mg	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
599	Oxycodone/naloxone prolonged release tablets 20 mg /10 mg	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件:  6  💬
600	Oxycodone/naloxone prolonged release tablets 20/10 mg	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
601	Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件:  6  💬
602	Oxycodone/naloxone prolonged release tablets 5/2.5 mg	Naloxone	5件: D01340, D03783, D05312, D05462, D08249 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
603	P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),	Pramipexole	5件: D00559, D02562, D05575, D08469, D10829 💬	4件: DRD2, DRD3, DRD4, MAOB 💬	18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway	1件:  6  💬
604	P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),	Pramipexole	5件: D00559, D02562, D05575, D08469, D10829 💬	4件: DRD2, DRD3, DRD4, MAOB 💬	18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway	1件:  6  💬
605	Pantoprazole	Pantoprazole	2件: D02593, D05353 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	2件: 13, 65 💬
606	Paroxetine & prednisolone	Paroxetine	12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬	2件: NR3C1, SLC6A4 💬	3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	1件: 46 💬
607	Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp	Paroxetine	12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬	2件: NR3C1, SLC6A4 💬	3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	1件: 46 💬
608	Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp	Paroxetine	12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬	2件: NR3C1, SLC6A4 💬	3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	1件: 46 💬
609	Peg-liposomal prednisolone sodium phosphate	Phosphate ion	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 13, 97 💬
610	Pentasa 2g sachet prolonged release granules (95%)	-	-	-	-	1件: 97 💬
611	Pentasa compact 2g, granulate with prolonged release	-	-	-	-	1件: 97 💬
612	Pentasa compact 4g, granulate with prolonged release	-	-	-	-	1件: 97 💬
613	Pentasa prolonged release granules 2g	-	-	-	-	1件: 97 💬
614	Pentasa sachet 1 g prolonged release granules	-	-	-	-	1件: 96 💬
615	Peptidic+probiotic	-	-	-	-	1件: 96 💬
616	Peri-neural dexamethasone 1 mg	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
617	Ph. eur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid	Propanoic acid	1件: D02310 💬	-	-	1件:  6  💬
618	Phenylalanine-free protein substitute in tablet form (xphe minis)	Phenylalanine	1件: D00021 💬	-	-	1件: 240 💬
619	Phenylalanine-free protein substitute tablets	Phenylalanine	1件: D00021 💬	-	-	1件: 240 💬
620	Pheur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid	Propanoic acid	1件: D02310 💬	-	-	1件:  6  💬
621	Phosphate and betamethasone acetate, 2 ml.	Acetate	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 235 💬
622	Piperacillin-tazobactam combination product	Piperacillin	4件: D00466, D00660, D02251, D08380 💬	-	-	1件: 299 💬
623	Pla-pru-pla-pru	-	-	-	-	1件: 99 💬
624	Pla-pru-pru-pla	-	-	-	-	1件: 99 💬
625	Plant cell expressed recombinant glucocerebrosidase (prgcd)	Taliglucerase alfa	1件: D09675 💬	1件: GBA 💬	4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism	1件: 19 💬
626	Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología prgf-system (bti)	-	-	-	-	1件: 96 💬
627	Plegridy - 125 mcg - soluzione iniettabile - uso sottocutaneo - penna preriempita - 0,5 ml - 6 penne preriempite	-	-	-	-	1件: 13 💬
628	Pn 200 tablets (500 mg naproxen and 20 mg omeprazole)	Naproxen	5件: D00118, D00455, D01207, D05259, D05261 💬	4件: ATP4A, ATP4B, PTGS1, PTGS2 💬	26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	2件: 46, 271 💬
629	Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate	Aluminium	-	-	-	1件: 46 💬
630	Po ciprofloxacin	Ciprofloxacin	2件: D00186, D02216 💬	-	-	1件: 299 💬
631	Polaprezinc	Polaprezinc	1件: D01611 💬	-	-	2件: 96, 97 💬
632	Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with n-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1)	Diethyl ether	2件: D01772, D06078 💬	1件: PTH1R 💬	3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action	1件: 235 💬
633	Pomalidomide and dexamethasone	Dexamethasone	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D08976 💬	3件: IL6, NR3C1, TNF 💬	79件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 28 💬
634	Pomalidomide oral product	Pomalidomide	1件: D08976 💬	2件: IL6, TNF 💬	78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 227 💬
635	Pr	-	-	-	-	1件: 41 💬
636	Pr oxycodone	Oxycodone	3件: D03783, D05312, D05462 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件:  6  💬
637	Pr-06410293	-	-	-	-	1件: 46 💬
638	Pr001	-	-	-	-	1件: 19 💬
639	Pr001a	-	-	-	-	1件:  6  💬
640	Pr006	-	-	-	-	1件: 127 💬
641	Pr1	-	-	-	-	1件: 51 💬
642	Pralia 60 mg subcutaneous injection syringe(denosumab)	Denosumab	1件: D03684 💬	1件: TNFSF11 💬	7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis	1件: 46 💬
643	Pralia 60mg subcutaneous injection syringe(denosumab)	Denosumab	1件: D03684 💬	1件: TNFSF11 💬	7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis	1件: 46 💬
644	Praluent	-	-	-	-	1件: 79 💬
645	Pramipexol	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
646	Pramipexol extended release	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
647	Pramipexol immediate release	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
648	Pramipexole	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	2件:  2 ,  6  💬
649	Pramipexole 0.125 mg tablets	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
650	Pramipexole 0.5 mg tablets	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
651	Pramipexole dihydrochloride	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
652	Pramipexole dihydrochloride extended-release tablets	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
653	Pramipexole dihydrochloride monohydrate	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
654	Pramipexole dihydrochloride monohydrate extended release	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
655	Pramipexole er	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
656	Pramipexole extended release	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
657	Pramipexole extended release tablet	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
658	Pramipexole hydrochloride sustained-release tablet (siforl®) specification: 0.26mg/ tablet (in pramipexole)	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
659	Pramipexole immediate release	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
660	Pramipexole immediate release tablet	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
661	Pramipexole ir	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
662	Pramipexole or ropinirole	Pramipexole	4件: D00559, D00784, D05575, D08489 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
663	Pramipexole sr	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
664	Prasterone	Prasterone	1件: D08409 💬	3件: AR, ESR1, ESR2 💬	11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway	1件: 49 💬
665	Prasterone (gl701)	Prasterone	1件: D08409 💬	3件: AR, ESR1, ESR2 💬	11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway	1件: 49 💬
666	Pravastatin	Pravastatin	2件: D00893, D08410 💬	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis	9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
667	Pravastatin sodium	Pravastatin	2件: D00893, D08410 💬	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis	1件: 265 💬
668	Praxol hydrochloride sustained release tablet specification: 0.375mg/ tablet (in pramipexole hydrochloride)	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
669	Prd2175434	-	-	-	-	1件: 113 💬
670	Prd4862257	-	-	-	-	1件: 46 💬
671	Prd5973697	-	-	-	-	1件: 97 💬
672	Prd806998	-	-	-	-	1件: 13 💬
673	Pre-filled syringe	-	-	-	-	1件: 46 💬
674	Prebiotics	-	-	-	-	1件: 96 💬
675	Prebiotics (prebiotin prebiotic fiber stick pac)	-	-	-	-	1件: 13 💬
676	Pred	-	-	-	-	1件: 46 💬
677	Pred + meth	-	-	-	-	1件: 46 💬
678	Predinose oral	-	-	-	-	1件: 70 💬
679	Prednihexal	-	-	-	-	1件: 46 💬
680	Prednihexal® 10mg tabletten	-	-	-	-	1件: 46 💬
681	Prednihexal® 20mg tabletten	-	-	-	-	1件: 46 💬
682	Prednihexal® 5mg tabletten	-	-	-	-	1件: 46 💬
683	Prednihexal® 5mg tabletten, prednihexal® 10mg tabletten	-	-	-	-	1件: 46 💬
684	Prednihexal® 5mg tabletten, prednihexal® 20mg tabletten	-	-	-	-	1件: 46 💬
685	Predniso	-	-	-	-	1件: 46 💬
686	Prednisolene tablets bp 1 mg	-	-	-	-	1件: 46 💬
687	Prednisolon	-	-	-	-	6件: 46, 50, 51, 66, 96, 97 💬
688	Prednisolon 1 mg jenapharm	-	-	-	-	1件: 41 💬
689	Prednisolon 5 mg jenapharm	-	-	-	-	1件: 41 💬
690	Prednisolon jenapharm	-	-	-	-	2件: 96, 97 💬
691	Prednisolon pfizer	-	-	-	-	1件: 50 💬
692	Prednisolona	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 51 💬
693	Prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
694	Prednisolone & dipyridamole	Dipyridamole	9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	3件: NR3C1, PDE4A, PDE5A 💬	7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
695	Prednisolone + mabthera	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 61 💬
696	Prednisolone 1mg tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
697	Prednisolone 2,5 mg tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
698	Prednisolone 20 mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
699	Prednisolone 40 mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
700	Prednisolone 5 mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 46, 51 💬
701	Prednisolone 5 mg jenapharm	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 41 💬
702	Prednisolone 5 mg tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
703	Prednisolone 5mg gastro-resistant tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 51 💬
704	Prednisolone 5mg tablet	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
705	Prednisolone acetate	Acetate	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 222 💬
706	Prednisolone and chlorambucil	Chlorambucil	9件: D00266, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 222 💬
707	Prednisolone and mycophenolate mofetil	Mycophenolate mofetil	12件: D00472, D00752, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05094, D05095, D05096 💬	3件: IMPDH1, IMPDH2, NR3C1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism	1件: 222 💬
708	Prednisolone and taper	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 51 💬
709	Prednisolone labesfal	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
710	Prednisolone sodium metasulphobenzoate	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
711	Prednisolone sodium phosphate	Phosphate ion	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 13, 97 💬
712	Prednisolone sodium succinate	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 95 💬
713	Prednisolone tablets b.p. 5mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
714	Prednisolone tablets bp	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
715	Prednisolone tablets bp 1 mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
716	Prednisolone tablets usp 5 mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
717	Prednisolone-dipyridamole	Dipyridamole	9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	3件: NR3C1, PDE4A, PDE5A 💬	7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
718	Prednisolone/prednisone	Prednisolone	9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 49 💬
719	Prednisoloni	-	-	-	-	1件: 51 💬
720	Prednisolonum	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 51 💬
721	Prednison	-	-	-	-	3件: 46, 84, 113 💬
722	Prednison 5, 20 léciva por. tablet nob	-	-	-	-	1件: 50 💬
723	Prednison 5, 20 léciva por. tablet nob.	-	-	-	-	1件: 50 💬
724	Prednison acis® 20 mg	-	-	-	-	2件: 43, 44 💬
725	Prednison acis® 5 mg	-	-	-	-	2件: 43, 44 💬
726	Prednisona	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 46, 49, 222 💬
727	Prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	47件:  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
728	Prednisone (and methylprednisolone)	Methylprednisolone	7件: D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 43 💬
729	Prednisone + inhibace/cozaar	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
730	Prednisone - azathioprine	Azathioprine	3件: D00238, D00473, D03033 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 11 💬
731	Prednisone 0,5 mg/kg orally on alternate days	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 222 💬
732	Prednisone 1 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
733	Prednisone 15 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
734	Prednisone 2 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
735	Prednisone 3 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
736	Prednisone 4 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
737	Prednisone 5 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 46, 66 💬
738	Prednisone 5 mg tablets	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 113 💬
739	Prednisone 7.5 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
740	Prednisone acetate	Acetate	2件: D00473, D08416 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 40, 49, 224 💬
741	Prednisone acetate tablets	Acetate	2件: D00473, D08416 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 224 💬
742	Prednisone alone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 11, 66 💬
743	Prednisone and belimumab	Belimumab	2件: D00473, D03068 💬	2件: NR3C1, TNFSF13B 💬	5件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis	1件: 300 💬
744	Prednisone and cyclophosphamide	Cyclophosphamide	3件: D00287, D00473, D07760 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
745	Prednisone and mycophenolate mofetil	Mycophenolate mofetil	5件: D00473, D00752, D05094, D05095, D05096 💬	3件: IMPDH1, IMPDH2, NR3C1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism	1件: 300 💬
746	Prednisone and ustekinumab treatment	Prednisone	2件: D00473, D09214 💬	4件: IL12A, IL12B, IL23A, NR3C1 💬	27件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus	1件: 41 💬
747	Prednisone arrow 20mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
748	Prednisone arrow 5 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
749	Prednisone capsules	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 41 💬
750	Prednisone discontinuation	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 49 💬
751	Prednisone in full dose	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
752	Prednisone or prednisolone	Prednisolone	9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
753	Prednisone plus cyclophosphamide	Cyclophosphamide	3件: D00287, D00473, D07760 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
754	Prednisone tablets usp, 1 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 41, 46 💬
755	Prednisone tablets usp, 2.5 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 41 💬
756	Prednisone tablets usp, 5 mg	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 41, 46 💬
757	Prednisone tablets, usp	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 41, 43, 44 💬
758	Prednisone therapy and pharmacokinetic	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 41 💬
759	Prednisone treatment	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 41 💬
760	Prednisone, ciclosporin and mycophenolate mofetil	Cyclosporine	6件: D00184, D00473, D00752, D05094, D05095, D05096 💬	8件: IMPDH1, IMPDH2, NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	36件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 222 💬
761	Prednisone, cyclophosphamide	Cyclophosphamide	3件: D00287, D00473, D07760 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 40 💬
762	Prednisone, fk506, mmf	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 222 💬
763	Prednisone, low dose rituximab	Prednisone	2件: D00473, D02994 💬	2件: MS4A1, NR3C1 💬	2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	1件: 61 💬
764	Prednisone, methylprednisolone,cyclophosphamides	Methylprednisolone	7件: D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 42, 43, 45 💬
765	Prednisone/prednisolone	Prednisolone	9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 35 💬
766	Prednizolon	-	-	-	-	1件: 51 💬
767	Prednizolonas	-	-	-	-	1件: 51 💬
768	Prefilled liquid etanercept(yisaipu)	Etanercept	1件: D00742 💬	2件: LTA, TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 271 💬
769	Prefilled syringe delivery of golimumab	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 97 💬
770	Prefolic*30cpr gastror 15mg	-	-	-	-	1件: 299 💬
771	Pregabalin	Pregabalin	1件: D02716 💬	4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬	7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway	5件: 13, 36, 46, 70, 298 💬
772	Pregabalin 75mg	Pregabalin	1件: D02716 💬	4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬	7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway	1件: 70 💬
773	Preimplantation factor	Preimplantation factor	-	-	-	1件: 95 💬
774	Preladenant	Preladenant	1件: D09717 💬	1件: ADORA2A 💬	7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	1件:  6  💬
775	Preladenant 10 mg tablet	Preladenant	1件: D09717 💬	1件: ADORA2A 💬	7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	1件:  6  💬
776	Preladenant 2 mg tablet	Preladenant	1件: D09717 💬	1件: ADORA2A 💬	7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	1件:  6  💬
777	Preladenant 5 mg tablet	Preladenant	1件: D09717 💬	1件: ADORA2A 💬	7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	1件:  6  💬
778	Premarin and provera	-	-	-	-	1件: 49 💬
779	Premarin ®	-	-	-	-	1件:  6  💬
780	Preotact	-	-	-	-	1件: 235 💬
781	Preparative regimen 4-6 weeks after leukapheresis	-	-	-	-	1件: 96 💬
782	Prepulsid	-	-	-	-	1件: 13 💬
783	Preservative free artificial tear gel.	-	-	-	-	1件: 157 💬
784	Prevenar	-	-	-	-	1件: 65 💬
785	Prevenar 13	-	-	-	-	2件: 46, 96 💬
786	Prevenar vaccination	-	-	-	-	1件: 46 💬
787	Prevenar vaccine	-	-	-	-	1件: 46 💬
788	Prevenar13	-	-	-	-	2件: 19, 265 💬
789	Prevenar® and pneumo23®	-	-	-	-	1件: 49 💬
790	Previously known as r935788	-	-	-	-	1件: 46 💬
791	Previously referred to as medi2070 and amg 139	-	-	-	-	2件: 96, 97 💬
792	Previously referred to as medi2070 and amg 139, agn-151-598	-	-	-	-	1件: 96 💬
793	Prgcd	Taliglucerase alfa	1件: D09675 💬	1件: GBA 💬	4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism	1件: 19 💬
794	Pridia (donepezil hydrochloride) 5mg	Donepezil	2件: D00670, D07869 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	1件:  6  💬
795	Pridia 10mg	-	-	-	-	1件:  6  💬
796	Pridia 5mg	-	-	-	-	1件:  6  💬
797	Pridiopidine	-	-	-	-	1件:  8  💬
798	Pridopidina	-	-	-	-	1件:  8  💬
799	Pridopidine	Pridopidine	1件: D09953 💬	1件: DRD2 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	3件:  2 ,  6 ,  8  💬
800	Pridopidine (90 mg)	Pridopidine	1件: D09953 💬	1件: DRD2 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  8  💬
801	Pridopidine hydrochloride	Pridopidine	1件: D09953 💬	1件: DRD2 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  8  💬
802	Prim-dj2727	-	-	-	-	2件:  6 , 97 💬
803	Primary cervical dystonia (trihexyphenidyl)	Trihexyphenidyl	2件: D00787, D08638 💬	5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway	1件:  6  💬
804	Primavanserin tartrate	-	-	-	-	1件:  6  💬
805	Primus	Florasulam	-	-	-	1件: 46 💬
806	Prior donepezil 5mg	Donepezil	2件: D00670, D07869 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	1件:  6  💬
807	Prior donzepezil 10mg	-	-	-	-	1件:  6  💬
808	Privigen	-	-	-	-	4件: 11, 14, 51, 65 💬
809	Privigen 100 mg/ml, solution pour perfusion	-	-	-	-	1件: 53 💬
810	Privigen 100mg/ml	-	-	-	-	1件: 85 💬
811	Privigen®	-	-	-	-	3件: 14, 63, 65 💬
812	Privigen® 100mg/ml at the dose of 2g/kg of body weight	-	-	-	-	1件: 53 💬
813	Prm-151	PRM-151	-	-	-	1件: 85 💬
814	Prn1008	-	-	-	-	1件: 35 💬
815	Prn1008 (rilzabrutinib)	-	-	-	-	1件: 35 💬
816	Prn1008 freebase	-	-	-	-	1件: 35 💬
817	Prn1008 oral tablet	-	-	-	-	1件: 35 💬
818	Prn2246	-	-	-	-	1件: 13 💬
819	Pro044	-	-	-	-	1件: 113 💬
820	Pro044 iv	-	-	-	-	1件: 113 💬
821	Pro044 iv 6 mg/kg	-	-	-	-	1件: 113 💬
822	Pro044 iv 9 mg/kg	-	-	-	-	1件: 113 💬
823	Pro044 sc	-	-	-	-	1件: 113 💬
824	Pro044 sc 6 mg/kg	-	-	-	-	1件: 113 💬
825	Pro045	-	-	-	-	1件: 113 💬
826	Pro045, 0.15 mg/kg/week	-	-	-	-	1件: 113 💬
827	Pro045, 1.0 mg/kg/week	-	-	-	-	1件: 113 💬
828	Pro045, 3.0 mg/kg/week	-	-	-	-	1件: 113 💬
829	Pro045, 6.0 mg/kg/week	-	-	-	-	1件: 113 💬
830	Pro045, 9.0 mg/kg/week	-	-	-	-	1件: 113 💬
831	Pro045, selected dose	-	-	-	-	1件: 113 💬
832	Pro051	-	-	-	-	1件: 113 💬
833	Pro053	-	-	-	-	1件: 113 💬
834	Pro145223	-	-	-	-	1件: 97 💬
835	Pro145223 (ro5490261)	-	-	-	-	1件: 97 💬
836	Pro283698	-	-	-	-	1件: 46 💬
837	Probenecid	Probenecid	1件: D00475 💬	-	-	1件: 25 💬
838	Probiotic	-	-	-	-	7件:  2 ,  6 , 93, 96, 97, 193, 266 💬
839	Probiotic - vsl#3	-	-	-	-	1件: 96 💬
840	Probiotic capsule	-	-	-	-	1件:  6  💬
841	Probiotic capsules containing lactobacillus rhamnosus gr-1 and l. reuteri rc-14	-	-	-	-	1件: 46 💬
842	Probiotic formula capsule	-	-	-	-	1件: 97 💬
843	Probiotic mixture	-	-	-	-	2件: 96, 97 💬
844	Probiotic product - cap	-	-	-	-	1件: 53 💬
845	Probiotic treatment	-	-	-	-	1件: 294 💬
846	Probiotic-lactobacillus plantarum ps128	Lactobacillus plantarum	-	-	-	1件: 156 💬
847	Probiotics	-	-	-	-	4件: 94, 96, 97, 291 💬
848	Probiotics (visbiome®)	-	-	-	-	1件: 13 💬
849	Probiotics with prebiotic	-	-	-	-	1件:  6  💬
850	Probucol	Probucol	1件: D00476 💬	-	-	1件: 66 💬
851	Procedure: 12 lead electrocardiogram	-	-	-	-	1件: 19 💬
852	Procedure: 12-lead ecg	-	-	-	-	2件: 140, 144 💬
853	Procedure: 2 ml of whole blood sample will be collected on edta tube	Edetic acid	8件: D00052, D00571, D01802, D03943, D03944, D03945, D03946, D03947 💬	-	-	1件: 51 💬
854	Procedure: 2-hour holter monitor	Methamidophos	-	-	-	1件: 19 💬
855	Procedure: 3d electrocardiographic mapping (ecm)	-	-	-	-	1件: 58 💬
856	Procedure: 9% sodium chloride (nacl) iv	Chloride ion	1件: D02056 💬	-	-	1件: 78 💬
857	Procedure: [123i]-ibzm imaging	-	-	-	-	1件:  6  💬
858	Procedure: [123i]beta-cit and spect imaging	-	-	-	-	1件:  6  💬
859	Procedure: [123i]ß-cit and spect imaging	-	-	-	-	1件:  6  💬
860	Procedure: acupuncture	-	-	-	-	2件: 46, 70 💬
861	Procedure: ad-msc transdifferentiated hscs (ad-hscs)	-	-	-	-	1件: 60 💬
862	Procedure: adipose derived mesenchymal stem cells ( ad-mscs)	-	-	-	-	1件: 60 💬
863	Procedure: adipose tissue harvest	-	-	-	-	1件: 51 💬
864	Procedure: air stacking manuever	-	-	-	-	1件:  3  💬
865	Procedure: airway clearance technique	-	-	-	-	1件: 299 💬
866	Procedure: alcohol wipes vs. no alcohol wipes	Ethanol	4件: D00068, D02798, D04855, D06542 💬	-	-	1件: 13 💬
867	Procedure: allo bmt	-	-	-	-	1件: 65 💬
868	Procedure: allogeneic bone marrow transplantation	-	-	-	-	6件: 60, 65, 96, 164, 284, 285 💬
869	Procedure: allogeneic hematopoietic stem cell transplantation	-	-	-	-	8件: 28, 51, 60, 62, 65, 164, 284, 285 💬
870	Procedure: allogeneic hsc	-	-	-	-	1件: 65 💬
871	Procedure: allogeneic hsct	-	-	-	-	1件: 65 💬
872	Procedure: allogeneic stem cell transplant	-	-	-	-	1件: 60 💬
873	Procedure: allogeneic stem cell transplantation	-	-	-	-	3件: 19, 20, 62 💬
874	Procedure: allogenic stem cell transplantation	-	-	-	-	1件: 60 💬
875	Procedure: allograft	-	-	-	-	1件: 70 💬
876	Procedure: antiviral therapy	-	-	-	-	2件: 28, 60 💬
877	Procedure: apheresis	-	-	-	-	1件: 60 💬
878	Procedure: apheresis catheter placement	-	-	-	-	1件: 96 💬
879	Procedure: arginine and clonidine stimulation testing	Arginine	3件: D00281, D00604, D02982 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	1件: 78 💬
880	Procedure: arginine stimulation test after each limb	Arginine	1件: D02982 💬	-	-	1件: 78 💬
881	Procedure: arthroscopic synovial tissue biopsy	-	-	-	-	1件: 46 💬
882	Procedure: assessment of therapy complications	-	-	-	-	1件: 60 💬
883	Procedure: audiological and ear, nose and throat examination	-	-	-	-	1件: 78 💬
884	Procedure: autologous bone marrow transplantation	-	-	-	-	2件: 13, 28 💬
885	Procedure: autologous cd34+hpc transplantation (hsct)	-	-	-	-	1件: 49 💬
886	Procedure: autologous hematopoietic stem cell transplant	-	-	-	-	1件: 13 💬
887	Procedure: autologous hematopoietic stem cell transplantation	-	-	-	-	6件: 11, 13, 14, 28, 49, 51 💬
888	Procedure: autologous hematopoietic stem cell transplantation (asct)	-	-	-	-	1件: 28 💬
889	Procedure: autologous peripheral blood stem cell transplantation	-	-	-	-	8件: 28, 40, 41, 42, 45, 46, 49, 283 💬
890	Procedure: autologous stem cell transplant	-	-	-	-	2件: 28, 96 💬
891	Procedure: autologous stem cell transplantation	-	-	-	-	2件: 13, 28 💬
892	Procedure: autologous-autologous tandem hematopoietic stem cell transplantation	-	-	-	-	1件: 28 💬
893	Procedure: b-lines se	-	-	-	-	3件: 58, 86, 215 💬
894	Procedure: ballon pulmonary angioplasty	-	-	-	-	1件: 88 💬
895	Procedure: balloon pulmonary angioplasty (bpa)	-	-	-	-	1件: 88 💬
896	Procedure: bee venom pharmacopuncture	-	-	-	-	1件: 70 💬
897	Procedure: behavior and neuropsychometric evaluations	-	-	-	-	1件: 78 💬
898	Procedure: biliary stent	-	-	-	-	1件: 300 💬
899	Procedure: biofluid samplings	-	-	-	-	1件:  6  💬
900	Procedure: biopsies	-	-	-	-	1件: 97 💬
901	Procedure: biopsy	-	-	-	-	3件: 51, 78, 193 💬
902	Procedure: biospecimen collection	-	-	-	-	1件: 159 💬
903	Procedure: blood analysis	-	-	-	-	1件:  6  💬
904	Procedure: blood collection for pk testing (15 mins before injection)	-	-	-	-	1件: 46 💬
905	Procedure: blood collection for pk testing (15 minutes post injection)	-	-	-	-	1件: 46 💬
906	Procedure: blood collection for pk testing (18-20 hours post injection)	-	-	-	-	1件: 46 💬
907	Procedure: blood collection for pk testing (180 minutes post injection)	-	-	-	-	1件: 46 💬
908	Procedure: blood collection for pk testing (60 minutes post injection)	-	-	-	-	1件: 46 💬
909	Procedure: blood collection for pk testing (after injection)	-	-	-	-	1件: 46 💬
910	Procedure: blood draw	-	-	-	-	5件:  6 , 19, 65, 231, 299 💬
911	Procedure: blood draw.	-	-	-	-	2件: 231, 299 💬
912	Procedure: blood draws	-	-	-	-	1件: 78 💬
913	Procedure: blood sample	-	-	-	-	1件: 65 💬
914	Procedure: blood sampling for determination of serum zn	-	-	-	-	1件: 299 💬
915	Procedure: blood sampling from infant	-	-	-	-	3件: 46, 96, 271 💬
916	Procedure: blood sampling from mother	-	-	-	-	3件: 46, 96, 271 💬
917	Procedure: blood sampling from umbilical cord	-	-	-	-	3件: 46, 96, 271 💬
918	Procedure: blood sampling, endoscopy	-	-	-	-	1件: 97 💬
919	Procedure: blue light photopheresis	-	-	-	-	1件: 96 💬
920	Procedure: bone densitometry	-	-	-	-	1件: 162 💬
921	Procedure: bone marrow ablation with stem cell support	-	-	-	-	2件: 28, 60 💬
922	Procedure: bone marrow aspiration	-	-	-	-	2件: 60, 285 💬
923	Procedure: bone marrow infusion	-	-	-	-	1件: 36 💬
924	Procedure: bone marrow mononuclear cells	-	-	-	-	1件: 57 💬
925	Procedure: bone marrow or umbilical cord blood (ucg) stem cell transplantation	-	-	-	-	1件: 36 💬
926	Procedure: bone marrow transplant	-	-	-	-	1件: 60 💬
927	Procedure: bone marrow transplantation	-	-	-	-	4件: 51, 60, 284, 285 💬
928	Procedure: brain magnetic resonance imaging (mri)	-	-	-	-	1件: 17 💬
929	Procedure: brain mri/mrs/fmri	-	-	-	-	1件: 19 💬
930	Procedure: brain pet scan	-	-	-	-	3件:  5 ,  7 , 127 💬
931	Procedure: breast milk sampling	-	-	-	-	3件: 46, 96, 271 💬
932	Procedure: bronchoalveolar lavage (bal)	-	-	-	-	1件: 84 💬
933	Procedure: bronchoscopy with bal	-	-	-	-	1件: 299 💬
934	Procedure: bronchoscopy with bronchoalveolar lavage	-	-	-	-	1件: 84 💬
935	Procedure: cardiac monitoring	-	-	-	-	1件:  6  💬
936	Procedure: carotid ultrasound	-	-	-	-	1件: 78 💬
937	Procedure: cd3-depleted hematopoietic cell transplantation	-	-	-	-	1件: 60 💬
938	Procedure: cd34 selected haploidentical pbsct	-	-	-	-	1件: 285 💬
939	Procedure: cd34+ peripheral blood stem cell reinfusion	-	-	-	-	1件: 49 💬
940	Procedure: cd3±cd19 depleted hematopoietic stem cell transplantation	-	-	-	-	1件: 60 💬
941	Procedure: celiac block with triamcinolone and bupivicaine	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 298 💬
942	Procedure: chuna manipulation	-	-	-	-	1件: 70 💬
943	Procedure: chuna manual medicine	-	-	-	-	1件: 70 💬
944	Procedure: clobetasol propionate	Clobetasol	2件: D01272, D07715 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 162 💬
945	Procedure: colectomy	-	-	-	-	1件: 97 💬
946	Procedure: collagenase	Collagenase clostridium histolyticum	1件: D09596 💬	-	-	1件: 162 💬
947	Procedure: colonoscopy	-	-	-	-	1件: 97 💬
948	Procedure: colorectal biopsies	-	-	-	-	1件: 97 💬
949	Procedure: computed tomography	-	-	-	-	5件: 34, 40, 46, 49, 96 💬
950	Procedure: continuous glucose monitoring system (cgms)	Dextrose, unspecified form	-	-	-	1件: 299 💬
951	Procedure: continuous mononuclear cell collection (cmnc)	-	-	-	-	1件: 96 💬
952	Procedure: contrast sensitivity measurement	-	-	-	-	1件: 19 💬
953	Procedure: control group	-	-	-	-	1件: 34 💬
954	Procedure: conventional surgery	-	-	-	-	1件: 34 💬
955	Procedure: cord blood	-	-	-	-	1件: 60 💬
956	Procedure: cord blood infusion	-	-	-	-	1件: 60 💬
957	Procedure: coronary flow reserve se	-	-	-	-	3件: 58, 86, 215 💬
958	Procedure: ct scan	-	-	-	-	1件: 65 💬
959	Procedure: cupping	-	-	-	-	1件: 70 💬
960	Procedure: cyclophosphamide	Cyclophosphamide	2件: D00287, D07760 💬	-	-	1件: 65 💬
961	Procedure: datscan and spect imaging	-	-	-	-	1件:  6  💬
962	Procedure: dental evaluation	-	-	-	-	1件: 78 💬
963	Procedure: determination of growth hormone status	Somatotropin	1件: D02691 💬	1件: GHR 💬	5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	1件: 78 💬
964	Procedure: determination of objective and subjective pain threshold	-	-	-	-	1件: 17 💬
965	Procedure: dexa scan	-	-	-	-	3件: 19, 46, 96 💬
966	Procedure: dexa, blood tests, h.g.p.o, osseous age.	-	-	-	-	2件: 78, 193 💬
967	Procedure: diastolic function se	-	-	-	-	3件: 58, 86, 215 💬
968	Procedure: digital substraction angiography (dsa)	-	-	-	-	1件: 40 💬
969	Procedure: drug coated balloon (dcb)	-	-	-	-	1件: 40 💬
970	Procedure: dual energy x-ray absorptiometry (dexa)	-	-	-	-	1件: 299 💬
971	Procedure: dynamic contrast-enhanced magnetic resonance imaging	-	-	-	-	1件: 13 💬
972	Procedure: dysmorphology evaluation	-	-	-	-	1件: 78 💬
973	Procedure: ebb + tblb + bal	-	-	-	-	1件: 84 💬
974	Procedure: ebus guided transbronchial forceps biopsy (ebus-tbfb)	-	-	-	-	1件: 84 💬
975	Procedure: ebus guided transbronchial needle aspiration (ebus-tbna)	-	-	-	-	1件: 84 💬
976	Procedure: echocardiogram	-	-	-	-	1件: 19 💬
977	Procedure: echocardiography (tee)	-	-	-	-	1件: 58 💬
978	Procedure: electroacupuncture	-	-	-	-	2件:  6 , 70 💬
979	Procedure: electrophysiologic study	-	-	-	-	1件:  1  💬
980	Procedure: embryonic dopamine cell implant surgery	Dopamine	2件: D00633, D07870 💬	5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
981	Procedure: endobronchial forceps biopsy	-	-	-	-	1件: 84 💬
982	Procedure: endoscopic balloon dilatation	-	-	-	-	1件: 96 💬
983	Procedure: endoscopic drainage of the main pancreatic duct	-	-	-	-	1件: 298 💬
984	Procedure: endoscopic repair of myelomeningocele before 26 sa	-	-	-	-	1件: 118 💬
985	Procedure: endoscopic trans-sphenoidal adenoma resection	-	-	-	-	1件: 74 💬
986	Procedure: endothelial cell biopsy	-	-	-	-	1件: 78 💬
987	Procedure: enema	-	-	-	-	1件: 97 💬
988	Procedure: epidural local anesthetic injection	-	-	-	-	1件: 70 💬
989	Procedure: epidural steroid (dexamethasone) injection	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 70 💬
990	Procedure: epidural steroid injection	-	-	-	-	1件: 70 💬
991	Procedure: epidural steroid with local anesthetic injection	-	-	-	-	1件: 70 💬
992	Procedure: esophageal dilation	-	-	-	-	1件: 98 💬
993	Procedure: esophagogastroduodenoscopy	-	-	-	-	1件: 98 💬
994	Procedure: eua with seton placement if necessary	-	-	-	-	1件: 96 💬
995	Procedure: eus	-	-	-	-	1件: 96 💬
996	Procedure: eus-fna/ebus-tbna + bal	-	-	-	-	1件: 84 💬
997	Procedure: ex vivo immunotherapy	-	-	-	-	1件: 60 💬
998	Procedure: exergame	-	-	-	-	2件:  6 , 13 💬
999	Procedure: exhaled nitric oxide	Nitric Oxide	1件: D00074 💬	-	-	1件: 299 💬
1000	Procedure: exhaled nitric oxide assessment	Nitric Oxide	1件: D00074 💬	-	-	1件: 46 💬
1001	Procedure: extracorporeal photopheresis	-	-	-	-	2件: 46, 96 💬
1002	Procedure: extracorporeal shock wave lithotripsy	-	-	-	-	1件: 298 💬
1003	Procedure: fdg-pet	-	-	-	-	1件: 299 💬
1004	Procedure: fecal microbiota transplantation	-	-	-	-	1件: 97 💬
1005	Procedure: fecal microbiota transplantation (fmt) of fmp30 donor stool	-	-	-	-	1件: 13 💬
1006	Procedure: fetal surgery for mmc repair	-	-	-	-	1件: 118 💬
1007	Procedure: fibroscan	-	-	-	-	1件: 171 💬
1008	Procedure: fluoroscopic swallow evaluation	-	-	-	-	1件:  6  💬
1009	Procedure: fmt	-	-	-	-	2件: 96, 97 💬
1010	Procedure: fmt+mtx	-	-	-	-	1件: 46 💬
1011	Procedure: functional hepatic nitrogen clearance	Nitrogen	1件: D00083 💬	-	-	1件: 171 💬
1012	Procedure: gastrointestinal evaluation	-	-	-	-	1件: 78 💬
1013	Procedure: gastroscopy	-	-	-	-	1件: 97 💬
1014	Procedure: general anesthesia with tourniquet	-	-	-	-	1件: 46 💬
1015	Procedure: general anesthesia without tourniquet	-	-	-	-	1件: 46 💬
1016	Procedure: ghrh/arginine stimulation testing	Arginine	2件: D02982, D08523 💬	1件: GHRHR 💬	2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction	1件: 78 💬
1017	Procedure: glucagon stimulation test and insulin tolerance test	Glucagon	2件: D00116, D02118 💬	1件: GCGR 💬	2件: Glucagon signaling pathway, Neuroactive ligand-receptor interaction	1件: 78 💬
1018	Procedure: growth factors laboratory testing	-	-	-	-	1件: 78 💬
1019	Procedure: growth hormone stimulation test	Somatotropin	1件: D02691 💬	1件: GHR 💬	5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	1件: 299 💬
1020	Procedure: haplo hsct	-	-	-	-	1件: 60 💬
1021	Procedure: hematopoietic bone marrow transplantation	-	-	-	-	1件: 36 💬
1022	Procedure: hematopoietic stem cell therapy	-	-	-	-	1件: 13 💬
1023	Procedure: hematopoietic stem cell transplant	-	-	-	-	1件: 285 💬
1024	Procedure: hematopoietic stem cell transplantation	-	-	-	-	3件: 13, 65, 285 💬
1025	Procedure: hematopoietic stem cell transplantation (hsct)	-	-	-	-	1件: 13 💬
1026	Procedure: hepatocyte transplant	-	-	-	-	1件: 240 💬
1027	Procedure: hgpiv diagnosis test	-	-	-	-	1件: 299 💬
1028	Procedure: high frequency ultrasonography	-	-	-	-	1件: 46 💬
1029	Procedure: history and physical	-	-	-	-	1件: 231 💬
1030	Procedure: history and physical exam.	-	-	-	-	2件: 231, 299 💬
1031	Procedure: homar-ir diagnosis test	-	-	-	-	1件: 299 💬
1032	Procedure: home based balance training	Isoxaflutole	-	-	-	2件:  6 , 13 💬
1033	Procedure: hydrocortisone withdrawal	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
1034	Procedure: hyperbaric oxygen	Oxygen	1件: D00003 💬	-	-	1件: 97 💬
1035	Procedure: hyperbaric oxygen therapy	Oxygen	1件: D00003 💬	-	-	1件: 90 💬
1036	Procedure: hypercortisolism	-	-	-	-	1件: 75 💬
1037	Procedure: ileocecal resection	-	-	-	-	1件: 96 💬
1038	Procedure: ileocolonoscopy	-	-	-	-	1件: 96 💬
1039	Procedure: immunoadsorption	-	-	-	-	1件: 13 💬
1040	Procedure: immunosuppressive therapy (ist)	-	-	-	-	1件: 60 💬
1041	Procedure: impedance analysis	-	-	-	-	1件: 162 💬
1042	Procedure: implant procedure	-	-	-	-	1件: 46 💬
1043	Procedure: in vitro-treated bone marrow transplantation	-	-	-	-	1件: 60 💬
1044	Procedure: in vitro-treated peripheral blood stem cell transplantation	-	-	-	-	2件: 60, 65 💬
1045	Procedure: increased exercise intensity	-	-	-	-	1件: 113 💬
1046	Procedure: indirect calorimetry	-	-	-	-	1件: 299 💬
1047	Procedure: infection prophylaxis and management	-	-	-	-	2件: 28, 60 💬
1048	Procedure: infusion of saline	-	-	-	-	1件: 97 💬
1049	Procedure: injection of salivary glands	-	-	-	-	1件:  2  💬
1050	Procedure: injections on posterior bladder wall excluding the trigone	-	-	-	-	1件: 226 💬
1051	Procedure: injections upper aspect of trigone of urinary bladder	-	-	-	-	1件: 226 💬
1052	Procedure: instillation of fibrin glue	-	-	-	-	1件: 96 💬
1053	Procedure: intestinal surgery for crohn's disease	-	-	-	-	1件: 96 💬
1054	Procedure: intra-articular injection of etanercept	Etanercept	1件: D00742 💬	2件: LTA, TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
1055	Procedure: intra-articular injection of steroid	-	-	-	-	1件: 46 💬
1056	Procedure: intraluminal impedance	-	-	-	-	1件: 98 💬
1057	Procedure: intravenous catheter	-	-	-	-	1件: 231 💬
1058	Procedure: irradiation	-	-	-	-	1件: 13 💬
1059	Procedure: iv administration of genetically engineered hematopoietic stem/progenitors cells (hspcs)	-	-	-	-	1件: 285 💬
1060	Procedure: iv deployment of csvf in sterile normal saline iv solution	-	-	-	-	2件: 85, 229 💬
1061	Procedure: iv glucose tolerance test	Dextrose, unspecified form	-	-	-	1件: 299 💬
1062	Procedure: land exercises	-	-	-	-	1件: 46 💬
1063	Procedure: large bore (19g) histologic needle biopsy of the mediastinal lymph nodes	-	-	-	-	1件: 84 💬
1064	Procedure: lateral transperitoneal la	-	-	-	-	1件: 75 💬
1065	Procedure: left ventricular contractile reserve se	-	-	-	-	3件: 58, 86, 215 💬
1066	Procedure: left ventricular outflow tract gradient se	-	-	-	-	3件: 58, 86, 215 💬
1067	Procedure: leukapheresis	-	-	-	-	5件: 49, 51, 96, 284, 285 💬
1068	Procedure: leukopheresis	-	-	-	-	1件: 51 💬
1069	Procedure: liver biopsy	-	-	-	-	3件: 171, 231, 240 💬
1070	Procedure: liver transplantation	-	-	-	-	1件: 94 💬
1071	Procedure: long term oxygen therapy	Oxygen	1件: D00003 💬	-	-	1件: 88 💬
1072	Procedure: lumbar epidural injection	-	-	-	-	1件: 70 💬
1073	Procedure: lumbar interlaminar epidural steroid injection	-	-	-	-	1件: 70 💬
1074	Procedure: lumbar puncture	-	-	-	-	5件:  6 , 13, 19, 96, 97 💬
1075	Procedure: magnetic resonance imaging	-	-	-	-	1件: 19 💬
1076	Procedure: magnetic resonance imaging of the brain	-	-	-	-	1件: 78 💬
1077	Procedure: management of therapy complications	-	-	-	-	2件: 28, 60 💬
1078	Procedure: manual therapy	-	-	-	-	1件: 70 💬
1079	Procedure: marrow graft transplantation	-	-	-	-	1件: 326 💬
1080	Procedure: matched unrelated donor hematopoietic stem cell transplant	-	-	-	-	1件: 60 💬
1081	Procedure: measurement of growth, thyroid and sex hormone levels	-	-	-	-	1件: 78 💬
1082	Procedure: measurement of serum infliximab and anti-infliximab antibodies	Infliximab	1件: D02598 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 96 💬
1083	Procedure: meg	-	-	-	-	1件:  6  💬
1084	Procedure: mesenchymal stem cell transplantation	-	-	-	-	2件: 36, 274 💬
1085	Procedure: microcannula harvest adipose derived tissue stromal vascular fraction (tsvf)	-	-	-	-	2件: 85, 229 💬
1086	Procedure: mild procedure	-	-	-	-	1件: 70 💬
1087	Procedure: minor salivary gland (labial) biopsy	-	-	-	-	1件: 53 💬
1088	Procedure: mitral regurgitation se	-	-	-	-	3件: 58, 86, 215 💬
1089	Procedure: motion analysis	-	-	-	-	1件:  6  💬
1090	Procedure: mri	-	-	-	-	2件: 13, 78 💬
1091	Procedure: mri imaging with intravenous contrast with gadoterate meglumine	Gadoteric acid	2件: D01796, D08007 💬	-	-	1件: 53 💬
1092	Procedure: mri, fdg-pet/ct scans	-	-	-	-	1件: 34 💬
1093	Procedure: mri, venipuncture	-	-	-	-	1件: 49 💬
1094	Procedure: narrow band imaging	-	-	-	-	1件: 97 💬
1095	Procedure: neurology examination	-	-	-	-	1件: 78 💬
1096	Procedure: neuropsychological testing	-	-	-	-	1件: 78 💬
1097	Procedure: no celiac block	-	-	-	-	1件: 298 💬
1098	Procedure: no gas	-	-	-	-	2件: 86, 88 💬
1099	Procedure: non-myeloablative high dose immunosuppressive therapy conditioning (hdit)	-	-	-	-	1件: 49 💬
1100	Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation	-	-	-	-	6件: 28, 51, 60, 62, 65, 285 💬
1101	Procedure: ophthalmologic evaluation	-	-	-	-	1件: 78 💬
1102	Procedure: ophthalmology exam	-	-	-	-	1件: 19 💬
1103	Procedure: oral glucose tolerance test	Dextrose, unspecified form	-	-	-	1件: 299 💬
1104	Procedure: order of two elements of surgical procedure	-	-	-	-	1件: 51 💬
1105	Procedure: orthopedic evaluation	-	-	-	-	1件: 78 💬
1106	Procedure: other intervention(s)	-	-	-	-	1件: 70 💬
1107	Procedure: oxygen flow at the optic nerve head measurement	Oxygen	1件: D00003 💬	-	-	1件: 19 💬
1108	Procedure: padn	-	-	-	-	1件: 86 💬
1109	Procedure: pelvic floor physical therapy	-	-	-	-	1件: 226 💬
1110	Procedure: percutaneous endoscopic gastrostomy with jejunal extension (peg-j)	-	-	-	-	1件:  6  💬
1111	Procedure: percutaneous lumbar decompression	-	-	-	-	1件: 70 💬
1112	Procedure: peripheral blood stem cell transplantation	-	-	-	-	11件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬
1113	Procedure: peripheral blood stem cell transplantation (pbsct)	-	-	-	-	1件: 60 💬
1114	Procedure: pet/ct	-	-	-	-	1件:  6  💬
1115	Procedure: pft	-	-	-	-	1件: 89 💬
1116	Procedure: pharmacopuncture	-	-	-	-	1件: 70 💬
1117	Procedure: phlebotomy	-	-	-	-	1件: 254 💬
1118	Procedure: physical exam and updrs part iii assessment	-	-	-	-	1件:  6  💬
1119	Procedure: physiotherapy, exercise, percutaneous gastrostomy feeds	-	-	-	-	1件: 299 💬
1120	Procedure: pilocarpine	Pilocarpine	3件: D00525, D02200, D05478 💬	2件: CHRM2, CHRM3 💬	13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway	1件: 53 💬
1121	Procedure: planar image with both hands in field of view	-	-	-	-	1件: 46 💬
1122	Procedure: plasma exchange	-	-	-	-	5件: 13, 43, 44, 64, 222 💬
1123	Procedure: plasma exchange (pe)	-	-	-	-	2件: 66, 220 💬
1124	Procedure: plasmapheresis	-	-	-	-	3件: 11, 49, 222 💬
1125	Procedure: plex	-	-	-	-	1件: 11 💬
1126	Procedure: plf with autograft	-	-	-	-	1件: 70 💬
1127	Procedure: positron emission tomography	-	-	-	-	4件: 40, 46, 49, 96 💬
1128	Procedure: posterior ra	-	-	-	-	1件: 75 💬
1129	Procedure: posterolateral spinal fusion with instrumentation	-	-	-	-	1件: 70 💬
1130	Procedure: power doppler ultrasonography	-	-	-	-	1件: 46 💬
1131	Procedure: pre liver transplantation laparoscopic hand assisted staging	-	-	-	-	1件: 94 💬
1132	Procedure: psychiatric evaluation	-	-	-	-	1件: 78 💬
1133	Procedure: pulmonary endarterectomy	-	-	-	-	1件: 88 💬
1134	Procedure: pulmonary endarteriectomy	-	-	-	-	1件: 88 💬
1135	Procedure: pulmonary function testing	-	-	-	-	3件:  2 , 228, 299 💬
1136	Procedure: pulmonary function testing.	-	-	-	-	2件: 231, 299 💬
1137	Procedure: pulmonary hemodynamics se	-	-	-	-	3件: 58, 86, 215 💬
1138	Procedure: quality-of-life assessment	-	-	-	-	3件: 28, 34, 51 💬
1139	Procedure: quantiferon-tb gold assay	Gold	-	-	-	1件: 46 💬
1140	Procedure: quantitative chemical shift imaging (qcsi)	-	-	-	-	1件: 19 💬
1141	Procedure: radiation therapy	-	-	-	-	3件: 13, 284, 285 💬
1142	Procedure: radiographs of the thoracic and lumbar spine	-	-	-	-	1件: 162 💬
1143	Procedure: rectal dialysis	-	-	-	-	1件: 97 💬
1144	Procedure: rectosigmoidoscopy	-	-	-	-	1件: 97 💬
1145	Procedure: reduced intensity allogeneic hematopoietic stem cell transplantation	-	-	-	-	1件: 51 💬
1146	Procedure: reduced intensity allogeneic transplant	-	-	-	-	2件: 49, 51 💬
1147	Procedure: renal sympathetic denervation	-	-	-	-	1件: 67 💬
1148	Procedure: repair of cdh w/alloderm	-	-	-	-	1件: 294 💬
1149	Procedure: repair of cdh w/sis gold	Gold	-	-	-	1件: 294 💬
1150	Procedure: rf catheter ablation	-	-	-	-	1件: 58 💬
1151	Procedure: routine drainage surgery	-	-	-	-	1件: 96 💬
1152	Procedure: saline injection	-	-	-	-	1件: 113 💬
1153	Procedure: sedation with iv propofol	Propofol	1件: D00549 💬	16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction	1件:  6  💬
1154	Procedure: self bone marrow transplant	-	-	-	-	1件: 51 💬
1155	Procedure: sham	-	-	-	-	2件: 90, 303 💬
1156	Procedure: sham cystoscopy procedure	-	-	-	-	1件: 226 💬
1157	Procedure: sham hyperbaric air	-	-	-	-	1件: 97 💬
1158	Procedure: sham padn	-	-	-	-	1件: 86 💬
1159	Procedure: sham procedure	-	-	-	-	1件:  3  💬
1160	Procedure: sham surgery	-	-	-	-	1件:  6  💬
1161	Procedure: sialoendoscopy	-	-	-	-	1件: 53 💬
1162	Procedure: sigmoidoscopy	-	-	-	-	1件: 97 💬
1163	Procedure: single photon emission computed tomography	-	-	-	-	1件: 34 💬
1164	Procedure: skeletal survey	-	-	-	-	1件: 19 💬
1165	Procedure: skin biopsy	-	-	-	-	2件: 19, 84 💬
1166	Procedure: skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 srt patients included.	-	-	-	-	1件: 102 💬
1167	Procedure: slit lamp assessment and intra-ocular pressure measurement	-	-	-	-	1件: 19 💬
1168	Procedure: small bowel follow trough	-	-	-	-	1件: 96 💬
1169	Procedure: sodium bicarbonate	Sodium bicarbonate	1件: D01203 💬	-	-	1件: 299 💬
1170	Procedure: spect imaging (180 minutes post-injection)	-	-	-	-	1件: 46 💬
1171	Procedure: spect imaging (60 minutes post-injection)	-	-	-	-	1件: 46 💬
1172	Procedure: speech and modified barium swallow study	Barium	-	-	-	1件: 19 💬
1173	Procedure: speech pathology evaluation	-	-	-	-	1件: 78 💬
1174	Procedure: spinal anesthesia with tourniquet	-	-	-	-	1件: 46 💬
1175	Procedure: spinal anesthesia without tourniquet	-	-	-	-	1件: 46 💬
1176	Procedure: spirometry	-	-	-	-	1件: 299 💬
1177	Procedure: spleen sample	-	-	-	-	1件: 61 💬
1178	Procedure: sputum collection	-	-	-	-	1件: 299 💬
1179	Procedure: stage ii surgical repair	-	-	-	-	1件: 211 💬
1180	Procedure: standardized fmt	-	-	-	-	1件: 97 💬
1181	Procedure: static, dynamic and functional balance exercises	Isoxaflutole	-	-	-	1件:  6  💬
1182	Procedure: static, dynamic and functional balance exercises with dual task	Isoxaflutole	-	-	-	1件:  6  💬
1183	Procedure: status post lung transplant	-	-	-	-	1件: 228 💬
1184	Procedure: stem cell collection	-	-	-	-	1件: 28 💬
1185	Procedure: stem cell infusion	-	-	-	-	5件: 28, 60, 65, 284, 285 💬
1186	Procedure: stem cell or umbilical cord blood transplantation	-	-	-	-	1件: 326 💬
1187	Procedure: stem cell transplant	-	-	-	-	5件: 19, 20, 65, 164, 284 💬
1188	Procedure: stem cell transplantation	-	-	-	-	6件: 19, 51, 60, 62, 65, 326 💬
1189	Procedure: stool samples	-	-	-	-	1件: 97 💬
1190	Procedure: supplemental oxygen via a mask	Oxygen	1件: D00003 💬	-	-	1件: 88 💬
1191	Procedure: surgery to implant human cns stem cells (hucns-sc)	-	-	-	-	1件: 19 💬
1192	Procedure: surgery treatment	-	-	-	-	1件: 291 💬
1193	Procedure: syngeneic bone marrow transplantation	-	-	-	-	3件: 11, 13, 14 💬
1194	Procedure: synovial biopsy	-	-	-	-	1件: 46 💬
1195	Procedure: taking of blood	-	-	-	-	1件: 113 💬
1196	Procedure: testosterone injection	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	1件: 265 💬
1197	Procedure: thymectomy plus prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 11 💬
1198	Procedure: thymic shielding during radiation	-	-	-	-	1件: 285 💬
1199	Procedure: tissue biopsy	-	-	-	-	1件:  1  💬
1200	Procedure: tissue samplings	-	-	-	-	1件:  6  💬
1201	Procedure: tof repair with trans-annular patch vs preservation of pv	-	-	-	-	1件: 215 💬
1202	Procedure: total body irradiation	-	-	-	-	6件: 19, 20, 51, 60, 65, 285 💬
1203	Procedure: total lymphoid irradiation	-	-	-	-	3件: 65, 284, 326 💬
1204	Procedure: total thyroidectomy	-	-	-	-	1件: 235 💬
1205	Procedure: total-body irradiation	-	-	-	-	1件: 51 💬
1206	Procedure: trans-right ventricular alcohol septal ablation (trvasa)	Ethanol	4件: D00068, D02798, D04855, D06542 💬	-	-	1件: 58 💬
1207	Procedure: transfusion	-	-	-	-	1件: 96 💬
1208	Procedure: transsphenoidal surgery treatment	-	-	-	-	1件: 74 💬
1209	Procedure: treatment according to current standards without knowledge of serum infliximab and anti-infliximab ab status	Infliximab	1件: D02598 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 96 💬
1210	Procedure: tuberculin skin test	-	-	-	-	1件: 46 💬
1211	Procedure: ultrasound	-	-	-	-	1件: 171 💬
1212	Procedure: umbilical cord blood therapy	Umbilical Cord Blood Hematopoietic Stem Cells	-	-	-	2件:  2 ,  6  💬
1213	Procedure: umbilical cord blood transplantation	-	-	-	-	5件: 60, 65, 284, 285, 326 💬
1214	Procedure: upper limb muscle block	-	-	-	-	1件: 149 💬
1215	Procedure: urinary collect	-	-	-	-	1件: 299 💬
1216	Procedure: urine collection	-	-	-	-	1件: 19 💬
1217	Procedure: urodynamic study	-	-	-	-	1件: 226 💬
1218	Procedure: use of an electronic data capture system by patients and physicians to assess patient-physician interactions & therapeutic decisions & outcomes in ra subjects.	Bifenthrin	-	-	-	1件: 46 💬
1219	Procedure: venipunctures	-	-	-	-	1件: 84 💬
1220	Procedure: videofluoroscopic swallowing study	-	-	-	-	1件:  2  💬
1221	Procedure: videofluoroscopic swallowing study (vfss)	-	-	-	-	1件:  2  💬
1222	Procedure: visual field testing	-	-	-	-	1件: 19 💬
1223	Procedure: warm compress prior to injection of glatiramer acetate	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
1224	Procedure: water exercises	Water	1件: D00001 💬	-	-	1件: 46 💬
1225	Procedure: whole body planar spect imaging (15 minutes post-injection)	-	-	-	-	1件: 46 💬
1226	Procedure: whole body planar spect imaging (18-20 hours post-injection)	-	-	-	-	1件: 46 💬
1227	Procedure: whole body planar spect imaging (180 minutes post-injection)	-	-	-	-	1件: 46 💬
1228	Procedure: whole body planar spect imaging (60 minutes post-injection)	-	-	-	-	1件: 46 💬
1229	Procedure: whole body protein turnover	-	-	-	-	4件: 19, 46, 96, 299 💬
1230	Procedure: whole body protein turnover study	-	-	-	-	1件: 299 💬
1231	Procedure: whole lung lavage(wll)	-	-	-	-	1件: 229 💬
1232	Procedure: wll	-	-	-	-	1件: 229 💬
1233	Procedure: wmt	-	-	-	-	1件: 96 💬
1234	Prochymal (remestemcel-l)	Remestemcel-L	1件: D09719 💬	-	-	1件: 96 💬
1235	Prochymal adult human mesenchymal stem cells	Remestemcel-L	1件: D09719 💬	-	-	1件: 96 💬
1236	Prochymal™ adult human mesenchymal stem cells	Remestemcel-L	1件: D09719 💬	-	-	1件: 96 💬
1237	Procysbi	-	-	-	-	1件: 19 💬
1238	Prodarsan	-	-	-	-	1件: 192 💬
1239	Products containing aminosalicylate	-	-	-	-	1件: 97 💬
1240	Products containing azathioprine or 6-mercaptopurine	Azathioprine	4件: D00161, D00238, D03033, D04931 💬	1件: HPRT1 💬	3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism	1件: 97 💬
1241	Progerinin	-	-	-	-	2件: 191, 333 💬
1242	Prograf	-	-	-	-	3件: 60, 222, 226 💬
1243	Prograft capsules	-	-	-	-	1件: 299 💬
1244	Progressive spacing of tnf-blocker injections	-	-	-	-	1件: 46 💬
1245	Prohance (gadoteridol)	Gadoteridol	1件: D01137 💬	-	-	1件: 13 💬
1246	Prolastin	-	-	-	-	3件: 231, 298, 299 💬
1247	Prolastin (drug)	-	-	-	-	1件: 299 💬
1248	Prolastin-c	-	-	-	-	2件: 231, 298 💬
1249	Prolastin-c, 120 mg/kg	-	-	-	-	1件: 231 💬
1250	Prolastin-c, 60 mg/kg	-	-	-	-	1件: 231 💬
1251	Proleukin	-	-	-	-	3件:  2 , 49, 65 💬
1252	Proleukin 18 mui	-	-	-	-	1件:  2  💬
1253	Proleukin® s	-	-	-	-	1件: 65 💬
1254	Prolia	-	-	-	-	1件: 274 💬
1255	Proline	Proline	1件: D00035 💬	-	-	2件: 94, 97 💬
1256	Prolonged release tablet	-	-	-	-	1件:  6  💬
1257	Prolonged-release fampridine	Dalfampridine	1件: D04127 💬	4件: KCNA4, KCNC3, KCND2, KCND3 💬	4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	1件: 13 💬
1258	Prolopa®	-	-	-	-	1件:  6  💬
1259	Prolotherapy solution of 20% dextrose	Dextrose, unspecified form	-	-	-	1件: 70 💬
1260	Promacta	-	-	-	-	2件: 63, 65 💬
1261	Promethazine	Promethazine	4件: D00480, D00494, D01242, D03290 💬	1件: HRH1 💬	3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction	1件: 96 💬
1262	Promethera hepastem	-	-	-	-	1件: 251 💬
1263	Prometic's immune globulin intravenous 10%	-	-	-	-	1件: 65 💬
1264	Promiten	-	-	-	-	1件: 97 💬
1265	Promixin	-	-	-	-	1件: 299 💬
1266	Promixin 1 million international units (iu) powder for nebuliser solution	-	-	-	-	1件: 299 💬
1267	Promixin*nebul 30monod 1mui	-	-	-	-	1件: 299 💬
1268	Promixin, 1 million international units (iu) powder for nebuliser solution	-	-	-	-	1件: 299 💬
1269	Promixin,1 millón de unidades internacionales,polvo para solución para inhalación por nebulizador	-	-	-	-	1件: 299 💬
1270	Promixin/tadim	-	-	-	-	1件: 299 💬
1271	Propagermanium	-	-	-	-	1件: 222 💬
1272	Propanoic acid	Propanoic acid	1件: D02310 💬	-	-	2件:  6 , 271 💬
1273	Propanolol	Propranolol	2件: D00483, D08443 💬	3件: ADRB1, ADRB2, ADRB3 💬	11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 296 💬
1274	Propantheline	Propantheline	1件: D00481 💬	5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway	1件: 26 💬
1275	Propantheline bromide	Propantheline	1件: D00481 💬	5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway	1件: 26 💬
1276	Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis a, hepatitis b, tick-borne encephalitis, meningococcal, pneumococcal)	-	-	-	-	1件: 13 💬
1277	Propionyl l-carnitine	Levocarnitine	3件: D02030, D02176, D04713 💬	-	-	1件: 97 💬
1278	Propionyl l-carnitine hydrochloride	Levocarnitine	3件: D02030, D02176, D04713 💬	-	-	1件: 97 💬
1279	Propionyl-l-carnitine	Levocarnitine	3件: D02030, D02176, D04713 💬	-	-	1件: 97 💬
1280	Propionylcarnitinhydrochlorid	-	-	-	-	1件: 97 💬
1281	Propiverine	Propiverine	1件: D08441 💬	9件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	42件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
1282	Propiverine hydrochloride	Propiverine	1件: D08441 💬	9件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	42件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 226 💬
1283	Propofol	Propofol	1件: D00549 💬	16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction	8件:  6 , 21, 22, 34, 46, 84, 98, 296 💬
1284	Propofol-lipuro	Propofol	1件: D00549 💬	16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction	1件:  6  💬
1285	Propolipid	-	-	-	-	1件: 46 💬
1286	Proposed inn - filgotinib	Filgotinib	1件: D10871 💬	1件: JAK1 💬	27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
1287	Propranolol	Propranolol	2件: D00483, D08443 💬	3件: ADRB1, ADRB2, ADRB3 💬	11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway	5件:  6 , 158, 167, 227, 278 💬
1288	Propranolol hcl cf 40 mg tablet	Propranolol	2件: D00483, D08443 💬	3件: ADRB1, ADRB2, ADRB3 💬	11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway	1件:  6  💬
1289	Propranolol treatment	Propranolol	2件: D00483, D08443 💬	3件: ADRB1, ADRB2, ADRB3 💬	11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 227 💬
1290	Propsoed inn - filgotinib	Filgotinib	1件: D10871 💬	1件: JAK1 💬	27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
1291	Propylene glycol	Propylene glycol	1件: D00078 💬	-	-	2件: 28, 51 💬
1292	Propylene glycol-free melphalan hydrochloride	Melphalan	2件: D00078, D00369 💬	-	-	1件: 28 💬
1293	Prosavin	-	-	-	-	1件:  6  💬
1294	Proscar*30cpr riv 5mg	-	-	-	-	1件:  6  💬
1295	Prostacyclin	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
1296	Prostanoids	-	-	-	-	1件: 51 💬
1297	Proteasa	-	-	-	-	1件: 299 💬
1298	Protease	-	-	-	-	1件: 299 💬
1299	Protease inhibitor	-	-	-	-	1件: 265 💬
1300	Protease inhibitors	-	-	-	-	1件: 265 💬
1301	Protectis	-	-	-	-	1件: 66 💬
1302	Protein	-	-	-	-	2件: 46, 67 💬
1303	Protein intake	-	-	-	-	1件: 240 💬
1304	Protein-carbohydrate supplementation	-	-	-	-	1件: 113 💬
1305	Proteína recombinante estimulante de la megacariopoyesis	-	-	-	-	1件: 63 💬
1306	Prothrombin	Prothrombin	-	-	-	1件: 288 💬
1307	Prothrombin complex concentrate	Factor IX Complex (Human)	-	-	-	1件: 288 💬
1308	Proton pump inhibitor (ppi)	-	-	-	-	1件: 298 💬
1309	Prototype capsule gdc-0134	-	-	-	-	1件:  2  💬
1310	Provigil	-	-	-	-	1件: 13 💬
1311	Provigil (modafinil)	Modafinil	1件: D01832 💬	-	-	1件: 13 💬
1312	Prozac	-	-	-	-	1件: 17 💬
1313	Prp	-	-	-	-	1件: 90 💬
1314	Prp injection	-	-	-	-	1件: 53 💬
1315	Prtx-100	-	-	-	-	1件: 46 💬
1316	Prtx-100 (staphylococcal protein a)	Bevifimod	-	-	-	1件: 63 💬
1317	Prtx-100 at 1.5 mcg/kg	-	-	-	-	1件: 46 💬
1318	Prtx-100 at 12.0 mcg/kg	-	-	-	-	1件: 46 💬
1319	Prtx-100 at 240 mcg	-	-	-	-	1件: 46 💬
1320	Prtx-100 at 3.0 mcg/kg	-	-	-	-	1件: 46 💬
1321	Prtx-100 at 420 mcg	-	-	-	-	1件: 46 💬
1322	Prtx-100 at 6.0 mcg/kg	-	-	-	-	1件: 46 💬
1323	Pru-pla-pla-pru	-	-	-	-	1件: 99 💬
1324	Pru-pla-pru-pla	-	-	-	-	1件: 99 💬
1325	Prucalopride	Prucalopride	1件: D09205 💬	1件: HTR4 💬	4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway	3件: 13, 51, 96 💬
1326	Prucalopride succinate	Prucalopride	1件: D09205 💬	1件: HTR4 💬	4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway	1件: 51 💬
1327	Prv-300	-	-	-	-	1件: 97 💬
1328	Prv-6527	-	-	-	-	1件: 96 💬
1329	Prv-6527 (jnj-40346527)	JNJ-40346527	-	-	-	1件: 96 💬
1330	Prv-6527(jnj-40346527)	JNJ-40346527	-	-	-	1件: 96 💬
1331	Prx-102	-	-	-	-	1件: 19 💬
1332	Prx-102 (pegunigalsidase alfa)	Pegunigalsidase alfa	1件: D11685 💬	-	-	1件: 19 💬
1333	Prx-112	-	-	-	-	1件: 19 💬
1334	Prx002	-	-	-	-	1件:  6  💬
1335	Prx002, elt2, anti-alpha-synuclein monoclonal antibody	-	-	-	-	1件:  6  💬
1336	Prx102	-	-	-	-	1件: 19 💬
1337	Psrs11.efs.il2rg.pre* retroviral vector	-	-	-	-	1件: 65 💬
1338	Psrs11.efs.il2rg.pre* retroviral vector transduce	-	-	-	-	1件: 65 💬
1339	Psrs11.efs.il2rg.pre* retroviral vector transduced cells	-	-	-	-	1件: 65 💬
1340	Pyridoxine plus prednisolone	Prednisolone	10件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02179, D03301, D08454 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 145 💬
1341	R(+) pramipexole dihydrochloride monohydrate	Pramipexole	2件: D00559, D05575 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  2  💬
1342	R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride	Benzofuran	-	-	-	1件:  6  💬
1343	R-salbutamol	Levosalbutamol	2件: D02147, D08124 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 49 💬
1344	R-salbutamol sulphate	Levosalbutamol	2件: D02147, D08124 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 49 💬
1345	Radiation: preparative radiation therapy	-	-	-	-	1件: 240 💬
1346	Ranolazine 1000 mg pr tablets	Ranolazine	2件: D05700, D05701 💬	-	-	1件: 58 💬
1347	Ranolazine 500 mg pr tablets	Ranolazine	2件: D05700, D05701 💬	-	-	1件: 58 💬
1348	Ranolazine 750 mg pr tablets	Ranolazine	2件: D05700, D05701 💬	-	-	1件: 58 💬
1349	Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die	Ranolazine	2件: D05700, D05701 💬	-	-	1件: 58 💬
1350	Rayos (delayed-release prednisone)	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
1351	Rebif 44 microgramos solución inyectable en jeringa precargada	-	-	-	-	1件: 13 💬
1352	Rebif 44 micrograms solution for injection in pre-filled syringe	-	-	-	-	1件: 13 💬
1353	Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack	-	-	-	-	1件: 13 💬
1354	Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack.	-	-	-	-	1件: 13 💬
1355	Rebif new formulation + ibuprofen prn	Ibuprofen	4件: D00126, D01122, D04490, D06606 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 13 💬
1356	Rebif new formulation + prophylactic ibuprofen	Ibuprofen	4件: D00126, D01122, D04490, D06606 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 13 💬
1357	Recifercept (proposed inn)	-	-	-	-	1件: 276 💬
1358	Recombinanat dna-derived human growth hormone produced in e.coli	Somatotropin	1件: D02691 💬	1件: GHR 💬	5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	1件: 78 💬
1359	Recombinant coagulation fviii fc – von willebrand factor – xten fusion protein	Von Willebrand Factor Human	-	-	-	1件: 288 💬
1360	Recombinant coagulation fviii fc – vonwillebrand factor – xten fusion protein	-	-	-	-	1件: 288 💬
1361	Recombinant dna-derived human growth hormone produced in e.coli	Somatotropin	1件: D02691 💬	1件: GHR 💬	5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	1件: 78 💬
1362	Recombinant factor fc fusion protein	-	-	-	-	2件: 46, 49 💬
1363	Recombinant human coagulation factor viii fc - von willebrand factor - xten fusion protein	Antihemophilic factor human	-	-	-	1件: 288 💬
1364	Recombinant human erythropoietin	Erythropoietin	1件: D03231 💬	1件: EPOR 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	1件: 13 💬
1365	Recombinant human erythropoietin(rhepo)	Erythropoietin	1件: D03231 💬	1件: EPOR 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	1件:  2  💬
1366	Recombinant human glucocerebrosidase (prgcd)	Taliglucerase alfa	1件: D09675 💬	1件: GBA 💬	4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism	1件: 19 💬
1367	Recombinant tnf-a receptor: igg fc fusion protein	-	-	-	-	2件: 46, 271 💬
1368	Recombinant truncated spint2 protease inhibitor	-	-	-	-	1件: 299 💬
1369	Rectal tacrolimus	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 97 💬
1370	Reduced intensity preparative regimen	-	-	-	-	3件: 62, 65, 284 💬
1371	Rege pro dressing	-	-	-	-	1件: 36 💬
1372	Remestemcel-l	Remestemcel-L	1件: D09719 💬	-	-	2件: 96, 97 💬
1373	Reminder product	-	-	-	-	1件: 19 💬
1374	Repaglinide	Repaglinide	1件: D00594 💬	2件: ABCC8, KCNJ11 💬	4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus	3件:  6 , 21, 299 💬
1375	Repaglinide and insulin	Repaglinide	1件: D00594 💬	2件: ABCC8, KCNJ11 💬	4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus	1件: 299 💬
1376	Repatha 140 mg solution for injection in pre-filled pen	-	-	-	-	1件: 79 💬
1377	Requip pr	-	-	-	-	1件:  6  💬
1378	Requip prolonged release	-	-	-	-	1件:  6  💬
1379	Requip xl prolonged-release	-	-	-	-	1件:  6  💬
1380	Revolade, promacta	-	-	-	-	1件: 63 💬
1381	Rhumab beta7, anti beta 7, pro145223	-	-	-	-	1件: 97 💬
1382	Rhumab beta7, anti beta7, pro145223	-	-	-	-	1件: 97 💬
1383	Rifaximin+omeprazole+miralax	Omeprazole	5件: D00455, D01207, D02554, D05259, D05261 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 96 💬
1384	Riociguat oral product	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 86 💬
1385	Rivastigmine	Rivastigmine	2件: D02558, D03822 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	3件:  5 ,  6 , 13 💬
1386	Rivastigmine capsule	Rivastigmine	2件: D02558, D03822 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	1件:  6  💬
1387	Rivastigmine cf	Rivastigmine	2件: D02558, D03822 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	1件:  6  💬
1388	Rivastigmine luye transdermal patch- 9.5mg/24h	Rivastigmine	2件: D02558, D03822 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	1件:  6  💬
1389	Rivastigmine patch 9.5 cm2	Rivastigmine	2件: D02558, D03822 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	1件:  6  💬
1390	Rivastigmine transdermal patch	Rivastigmine	2件: D02558, D03822 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	2件:  6 , 13 💬
1391	Rivastigmine transdermal system	Rivastigmine	2件: D02558, D03822 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	1件:  6  💬
1392	Rivastigmine transdermal system 13.3 mg/24 h	Rivastigmine	2件: D02558, D03822 💬	1件: ACHE 💬	2件: Cholinergic synapse, Glycerophospholipid metabolism	1件:  6  💬
1393	Roactemra 162 mg solution for injection in pre-filled syringe	-	-	-	-	1件: 41 💬
1394	Roactemra 162 mg solution injectable en seringue préremplie	-	-	-	-	1件: 46 💬
1395	Roactemra®ev product code: prd82321	-	-	-	-	1件: 46 💬
1396	Ropinirole hydrochloride prolonged release	Ropinirole	2件: D00784, D08489 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
1397	Ropinirole oral product	Ropinirole	2件: D00784, D08489 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
1398	Ropinirole pr	Ropinirole	2件: D00784, D08489 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
1399	Ropinirole pr, 2mg	Ropinirole	2件: D00784, D08489 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
1400	Ropinirole pr/xr	Ropinirole	2件: D00784, D08489 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
1401	Ropinirole pr/xr tablets	Ropinirole	2件: D00784, D08489 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
1402	Ropinirole prolonged release	Ropinirole	2件: D00784, D08489 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
1403	Ropinirole prolonged release/extended release(pr/xr)	Ropinirole	2件: D00784, D08489 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
1404	Rotigotine (reference product pr 2.1.1)	Rotigotine	1件: D05768 💬	1件: DRD2 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
1405	Rotigotine (test product pr 2.3.1)	Rotigotine	1件: D05768 💬	1件: DRD2 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
1406	Sait101 (proposed rituximab biosimilar)	Rituximab	1件: D02994 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	1件: 46 💬
1407	Salbutamol	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	9件:  3 , 11, 49, 85, 86, 111, 228, 256, 299 💬
1408	Salbutamol 4mg tablet	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 11 💬
1409	Salbutamol sulfate	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 111 💬
1410	Salbutamol sulfate ph. eur.	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 11 💬
1411	Salbutamol wzf 4 mg	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 11 💬
1412	Salofalk 3g gastro-resistant prolonged-release granules	-	-	-	-	1件: 97 💬
1413	Sandostatina - lar 20 mg/2.5 ml polvere e solvente per sospensione iniettabile flacone polvere + siringa preriempita 2.5 ml + 2 aghi	-	-	-	-	1件: 67 💬
1414	Sb12 (proposed eculizumab biosimilar)	Eculizumab	1件: D03940 💬	1件: C5 💬	9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	1件: 62 💬
1415	Sb2 (proposed biosimilar to infliximab)	Infliximab	1件: D02598 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
1416	Sb4 (proposed biosimilar to etanercept)	Etanercept	1件: D00742 💬	2件: LTA, TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
1417	Sb5 (proposed biosimilar to adalimumab)	Adalimumab	1件: D02597 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
1418	Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group)	Amitriptyline	7件: D00326, D00809, D00823, D01355, D02691, D07448, D08623 💬	4件: GHR, OPRM1, SLC6A2, SLC6A4 💬	9件: Cytokine-cytokine receptor interaction, Estrogen signaling pathway, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Serotonergic synapse, Synaptic vesicle cycle	1件: 78 💬
1419	Scopolamine, atropine, edaravone and dexmedetomidine	Atropine	9件: D00113, D00138, D00514, D01077, D01205, D01552, D02069, D03011, D03814 💬	8件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件:  2  💬
1420	Secukinumab 150 mg provided in 1.0 ml pre-filled syringes (pfss) for sc injection.	Secukinumab	1件: D09967 💬	1件: IL17A 💬	5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation	1件: 271 💬
1421	Simponi 50 mg solución inyectable en pluma precargada	-	-	-	-	1件: 46 💬
1422	Sirolimus oral liquid product 1mg/ml	Sirolimus	1件: D00753 💬	1件: MTOR 💬	50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway	1件: 278 💬
1423	Sirolimus oral product	Sirolimus	1件: D00753 💬	1件: MTOR 💬	50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway	2件: 89, 158 💬
1424	Sitagliptin	Sitagliptin	1件: D08516 💬	1件: DPP4 💬	1件: Protein digestion and absorption	4件:  6 , 75, 233, 299 💬
1425	Sitagliptin and metformin	Metformin	3件: D00944, D04966, D08516 💬	3件: DPP4, PRKAA1, PRKAA2 💬	20件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, mTOR signaling pathway	1件: 233 💬
1426	Solu-cortef (hydrocortisone)	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 83 💬
1427	Soluble prednisolone tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 145 💬
1428	Sotatercept with prednisone boost	Prednisone	2件: D00473, D09670 💬	2件: ACVR2A, NR3C1 💬	5件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway	1件: 284 💬
1429	Soy protein	-	-	-	-	2件:  6 , 96 💬
1430	Soy protein isolate	-	-	-	-	1件: 227 💬
1431	Staphylococcal protein a	Bevifimod	-	-	-	1件: 63 💬
1432	Stelara 90 mg solution for injection in pre-filled syringe	-	-	-	-	1件: 96 💬
1433	Stem/progenitor cells transplantation	-	-	-	-	2件: 90, 301 💬
1434	Steroid and proton pump inhibitor therapy	-	-	-	-	1件: 98 💬
1435	Strontium ranelate	Strontium ranelate	1件: D08468 💬	-	-	1件: 78 💬
1436	Study of the gene expression profile	-	-	-	-	1件: 51 💬
1437	Subcutaneous and intravenous prostacyclin	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
1438	Subcutaneous hydrocortisone	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
1439	Subcutaneous hydrocortisone 10mg	Hydrocortisone	1件: D00088 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件:  6  💬
1440	Subretinal injection of umbilical cord blood platelet-rich plasma (cb-prp)	-	-	-	-	1件: 90 💬
1441	Sulphasalazine + hydroxychloroquine or prednisolone	Hydroxychloroquine	9件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D08050 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
1442	Sustanon (testosterone)	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	1件: 113 💬
1443	Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil)	Azathioprine	8件: D00107, D00238, D00752, D03033, D05094, D05095, D05096, D08556 💬	7件: IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	35件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 11 💬
1444	Synthetic preimplantation factor	Preimplantation factor	-	-	-	1件: 95 💬
1445	T-cell depleted & cd34+select/w/stemcell enriched product	-	-	-	-	1件: 65 💬
1446	Tabalumab prefilled syringe	Tabalumab	1件: D10083 💬	1件: TNFSF13B 💬	4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis	2件: 46, 49 💬
1447	Tacrolimus	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	32件:  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
1448	Tacrolimus (advagraf)	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 227 💬
1449	Tacrolimus (prograf®)	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
1450	Tacrolimus (tacro)	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 65 💬
1451	Tacrolimus and mmf	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 299 💬
1452	Tacrolimus capsule	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 11 💬
1453	Tacrolimus capsule (low-dose)	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 227 💬
1454	Tacrolimus capsules	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	2件: 222, 299 💬
1455	Tacrolimus combined with prednisone	Prednisone	3件: D00107, D00473, D08556 💬	6件: NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 222 💬
1456	Tacrolimus prolonged-release hard capsules	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 299 💬
1457	Tacrolimus tablets	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件:  6  💬
1458	Tacrolimus with methotrexate	Methotrexate	4件: D00107, D00142, D02115, D08556 💬	7件: DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
1459	Taltz (80 mg solution for injection in pre-filled syringe)	-	-	-	-	1件: 271 💬
1460	Targinact 10 mg/5 mg prolonged-release tablets	-	-	-	-	2件:  6 , 226 💬
1461	Targinact 20 mg/10 mg prolonged-release tablets	-	-	-	-	1件:  6  💬
1462	Targinact 20mg/10 mg prolonged-release tablets	-	-	-	-	1件: 226 💬
1463	Targinact 5 mg/2.5 mg prolonged-release tablets	-	-	-	-	1件:  6  💬
1464	Targinact 5mg/2.5 mg prolonged-release tablets	-	-	-	-	1件: 226 💬
1465	Tasocitinib (proposed inn)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
1466	Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)	Hydrogen	-	-	-	1件:  6  💬
1467	Testosterone	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	8件:  1 ,  2 ,  3 , 13, 60, 78, 113, 265 💬
1468	Testosterone decanoate	Testosterone	7件: D00075, D00957, D00958, D00959, D06085, D06087, D08573 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	1件: 113 💬
1469	Testosterone enanthate	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	1件: 113 💬
1470	Testosterone isocaproate	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	1件: 113 💬
1471	Testosterone phenylpropionate	Testosterone	7件: D00075, D00957, D00958, D00959, D06085, D06087, D08574 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	1件: 113 💬
1472	Testosterone plus somatropin	Somatotropin	7件: D00075, D00957, D00958, D00959, D02691, D06085, D06087 💬	2件: AR, GHR 💬	8件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer	1件: 78 💬
1473	Testosterone propionate	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	1件: 113 💬
1474	Testosterone undecanoate	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	2件: 13, 60 💬
1475	Thalidomide, cyclophosphamide and prednisone	Cyclophosphamide	4件: D00287, D00473, D00754, D07760 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 331 💬
1476	The generic name is warfarin and many producers will be involved	Warfarin	3件: D00564, D01280, D08682 💬	2件: NQO1, VKORC1 💬	6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis	1件: 49 💬
1477	The gut mycobiota and microbiota profile	-	-	-	-	1件: 299 💬
1478	The investigational medicinal product (imp) may be labelled as either pf-04236921 106 mg/vial, clonal sc lyophilized form” or pf-04236921 powder for injection, 106 mg/vial”. supplies labelled with either nomenclature are equivalent.	-	-	-	-	1件: 96 💬
1479	The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta	-	-	-	-	1件: 96 💬
1480	The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta.	-	-	-	-	1件: 96 💬
1481	The lung mycobiota and microbiota profile	-	-	-	-	1件: 299 💬
1482	The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:	-	-	-	-	1件: 86 💬
1483	The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care:	-	-	-	-	1件: 86 💬
1484	Tildrakizumab prefilled syringe	Tildrakizumab	1件: D10400 💬	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	1件: 162 💬
1485	Tobi inhalant product	-	-	-	-	1件: 299 💬
1486	Tocilizumab prefilled syringe	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
1487	Tocilizumab sc 162 mg/0.9 ml pre-filled syringe with safety device (pfs)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
1488	Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 51 💬
1489	Tofacitinib (xeljanz®) 11mg prolonged release tablet	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
1490	Tofacitinib citrate (proposed commercial formulation - debossed)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	2件: 46, 97 💬
1491	Tofacitinib citrate (proposed commercial formulation debossed)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
1492	Tofacitinib citrate (proposed commercial formulation – debossed)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	2件: 46, 97 💬
1493	Tofacitinib citrate (proposed commercial formulation- debossed)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
1494	Tofacitinib citrate (proposed commercialformulation - debossed)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 97 💬
1495	Topical preparation h arm	-	-	-	-	1件: 13 💬
1496	Trade name depends on the source of the product	-	-	-	-	1件: 76 💬
1497	Trade name depends on the source of the product’	-	-	-	-	1件: 76 💬
1498	Transcon peg40 hgh, transiently pegylated hgh prodrug	-	-	-	-	1件: 78 💬
1499	Transdermal testosterone gel	Testosterone	6件: D00075, D00957, D00958, D00959, D06085, D06087 💬	1件: AR 💬	3件: Oocyte meiosis, Pathways in cancer, Prostate cancer	1件: 78 💬
1500	Transiently pegylated hgh prodrug	-	-	-	-	1件: 78 💬
1501	Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan	Alemtuzumab	5件: D00369, D00583, D01907, D02802, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	2件: 65, 164 💬
1502	Treat with lansoprazole 30 mg bid for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms	Lansoprazole	1件: D00355 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	1件: 98 💬
1503	Treatment systemic therapy (prednisone)	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 162 💬
1504	Treatment with systemic therapy (prednisone)	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 162 💬
1505	Treprostinil injectable product	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
1506	Trexan+salazopyrin+oxiklorin+prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
1507	Trexan+salazopyrin+oxiklorin+prednisolone + infliximab	Infliximab	9件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02598, D03301 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
1508	Triamcinolone	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
1509	Triamcinolone 40 milligrams (kenacort, bristol myers squip)	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
1510	Triamcinolone acetonide	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 35, 46, 56 💬
1511	Triamcinolone acetonide and normal saline solution	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 70 💬
1512	Triamcinolone hexacetonid (lederspan)	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
1513	Triamcinolone hexacetonide	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
1514	Triamcinolone hexacetonide (lederspan)	Triamcinolone	5件: D00385, D00983, D00984, D00985, D06216 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
1515	Trimethoprim	Trimethoprim	2件: D00145, D06236 💬	-	-	6件: 36, 44, 49, 60, 85, 299 💬
1516	Trimethoprim and sulfamethoxazole	Sulfamethoxazole	3件: D00145, D00447, D06236 💬	-	-	1件: 299 💬
1517	Trimethoprim sulfamethoxazole	Sulfamethoxazole	3件: D00145, D00447, D06236 💬	-	-	1件: 44 💬
1518	Trimethoprim sulfamethoxazole (tmp/smx)	Sulfamethoxazole	3件: D00145, D00447, D06236 💬	-	-	1件: 299 💬
1519	Trimethoprim sulfate	Sulfate ion	2件: D00145, D06236 💬	-	-	1件: 60 💬
1520	Trimethoprim-sulfamethoxazole	Sulfamethoxazole	3件: D00145, D00447, D06236 💬	-	-	2件: 49, 299 💬
1521	Trimethoprim/sulfamethoxazole	Sulfamethoxazole	3件: D00145, D00447, D06236 💬	-	-	1件: 299 💬
1522	Trimethoprim/sulfamethoxazole (tmp/smx)	Sulfamethoxazole	3件: D00145, D00447, D06236 💬	-	-	1件: 299 💬
1523	Ursodeoxycholic acid+low dose glucocorticoid(prednisone)	Prednisone	2件: D00473, D00734 💬	2件: NR1H4, NR3C1 💬	2件: Bile secretion, Neuroactive ligand-receptor interaction	1件: 93 💬
1524	Us tap bupivacaine/epinephrine	Bupivacaine	5件: D00095, D00996, D01450, D02149, D07552 💬	14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 96 💬
1525	Ustekinumab liquid in prefilled syringe	Ustekinumab	1件: D09214 💬	3件: IL12A, IL12B, IL23A 💬	26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus	1件: 84 💬
1526	Valproate, levocarnitine	Levocarnitine	4件: D00399, D02030, D02176, D04713 💬	7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬	17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件:  3  💬
1527	Valproic acid and levocarnitine	Levocarnitine	4件: D00399, D02030, D02176, D04713 💬	7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬	17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件:  3  💬
1528	Vancomycin pre-treat	Vancomycin	2件: D00212, D00926 💬	-	-	1件: 97 💬
1529	Vancomycin pre-treatment	Vancomycin	2件: D00212, D00926 💬	-	-	1件: 97 💬
1530	Vivomixx probiotics	-	-	-	-	1件: 51 💬
1531	Vwf-containing products	-	-	-	-	1件: 288 💬
1532	Vwf/fviii products	-	-	-	-	1件: 288 💬
1533	Whey protein	-	-	-	-	2件:  6 , 96 💬
1534	Whey protein&prebiotic supplement	-	-	-	-	1件: 46 💬
1535	Z102 (prednisolone and dipyridamole).	Dipyridamole	9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	3件: NR3C1, PDE4A, PDE5A 💬	7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
1536	Zavesca® prescription	-	-	-	-	1件: 256 💬
1537	Zoledronic acid kern pharma 4 mg/100 ml solution for infusion, generic medicinal product	Zoledronic acid	4件: D01968, D06378, D06379, D08689 💬	1件: FDPS 💬	4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis	1件: 274 💬
1538	Zoledronic acid kern pharma 4 mg/100 ml solution for infusion, generic medicinal product.	Zoledronic acid	4件: D01968, D06378, D06379, D08689 💬	1件: FDPS 💬	4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis	1件: 274 💬
1539	Zoledronic acid kern pharma 4 mg/100 ml solution for infusion,generic medicinal product	Zoledronic acid	4件: D01968, D06378, D06379, D08689 💬	1件: FDPS 💬	4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis	1件: 274 💬
1540	Zoledronic acid, pravastatin	Pravastatin	6件: D00893, D01968, D06378, D06379, D08410, D08689 💬	2件: FDPS, HMGCR 💬	6件: AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis	1件: 333 💬

先頭へ